[
    {
        "data": {
            "doi": "10.1002/cca.4064",
            "question": "What is the accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment in symptomatic people?",
            "gold_answer": "For people with symptoms suggestive of dementia, using recognized classification systems applied by an experienced clinician as the reference standard, average sensitivities of the clinical judgment by primary care physicians for the detection of dementia ranged from 34% to 91%, and specificities ranged from 58% to 99%. The pooled estimate was 58% for sensitivity and 89% for specificity. The positive and negative likelihood ratios were 5.3 and 0.47, respectively. Using the same reference standard for people with symptoms suggestive of dementia, average sensitivities of the clinical judgment by primary care physicians for the detection of cognitive impairment ranged from 58% to 97%, and specificities ranged from 40% to 88%. The pooled estimate was 84% for sensitivity and 73% for specificity. The positive and negative likelihood ratios were 3.1 and 0.23, respectively.",
            "gold_answer_terms": "SYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nCLINICAL (clinical): pertaining to medical care",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4064",
            "llm_answer": "The accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment in symptomatic people can vary depending on the study and population being evaluated. However, several studies suggest that primary care physicians have a moderate to high accuracy in diagnosing dementia, with sensitivity ranging from 60% to 90% and specificity ranging from 70% to 90%. However, the accuracy can be affected by factors such as the physician's experience, the quality of the clinical evaluation, and the use of standardized assessment tools. It is important to note that while primary care physicians can accurately diagnose dementia, specialist evaluation may be necessary for more complex or uncertain cases.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> What is the accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment in symptomatic people?[/INST]",
            "topic1": [
                "mental health"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Ciapponi, Agust\u00edn; K\u00f6pke, Sascha"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 200,
                            "score": 0.5,
                            "text": "The accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment in symptomatic people can vary depending on the study and population being evaluated.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 201,
                            "end": 401,
                            "score": 0.5,
                            "text": "However, several studies suggest that primary care physicians have a moderate to high accuracy in diagnosing dementia, with sensitivity ranging from 60% to 90% and specificity ranging from 70% to 90%.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 402,
                            "end": 572,
                            "score": 0.5,
                            "text": "However, the accuracy can be affected by factors such as the physician's experience, the quality of the clinical evaluation, and the use of standardized assessment tools.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 573,
                            "end": 741,
                            "score": 0.5,
                            "text": "It is important to note that while primary care physicians can accurately diagnose dementia, specialist evaluation may be necessary for more complex or uncertain cases.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4064",
            "question": "What is the accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment in symptomatic people?",
            "gold_answer": "For people with symptoms suggestive of dementia, using recognized classification systems applied by an experienced clinician as the reference standard, average sensitivities of the clinical judgment by primary care physicians for the detection of dementia ranged from 34% to 91%, and specificities ranged from 58% to 99%. The pooled estimate was 58% for sensitivity and 89% for specificity. The positive and negative likelihood ratios were 5.3 and 0.47, respectively. Using the same reference standard for people with symptoms suggestive of dementia, average sensitivities of the clinical judgment by primary care physicians for the detection of cognitive impairment ranged from 58% to 97%, and specificities ranged from 40% to 88%. The pooled estimate was 84% for sensitivity and 73% for specificity. The positive and negative likelihood ratios were 3.1 and 0.23, respectively.",
            "gold_answer_terms": "SYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nCLINICAL (clinical): pertaining to medical care",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4064",
            "llm_answer": "The accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment in symptomatic people can vary depending on the specific study and population being evaluated. However, research suggests that primary care physicians can accurately diagnose dementia or cognitive impairment in symptomatic individuals with a moderate to high degree of accuracy.\nA systematic review and meta-analysis published in the journal PLOS Medicine in 2018 found that the pooled sensitivity of primary care physicians' clinical judgment for dementia diagnosis was 73% (95% CI: 64-82%) and the pooled specificity was 86% (95% CI: 79-93%). However, the review also noted that the quality of the studies included was generally low and that there was significant heterogeneity between the studies.\nAnother study published in the Journal of General Internal Medicine in 2016 found that primary care physicians accurately diagnosed dementia in 81.1% of cases, but that the accuracy was lower for milder forms of cognitive impairment.\nIt's important to note that the accuracy of clinical judgment can be influenced by various factors, such as the physician's experience and training, the quality of the clinical evaluation, and the presence of comorbidities or other conditions that can affect cognitive function. Additionally, the diagnosis of dementia or cognitive impairment often requires a comprehensive evaluation, including a thorough medical history, physical examination, laboratory tests, and cognitive assessments, so the accuracy of the diagnosis may be higher when a multidisciplinary team is involved.\nIn summary, while the accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment can be moderate to high, it's important to consider the limitations of clinical judgment and the importance of a comprehensive evaluation to ensure accurate diagnosis and appropriate management.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> What is the accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment in symptomatic people?[/INST]",
            "topic1": [
                "mental health"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Ciapponi, Agust\u00edn; K\u00f6pke, Sascha"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 209,
                            "score": 0.5,
                            "text": "The accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment in symptomatic people can vary depending on the specific study and population being evaluated.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 210,
                            "end": 393,
                            "score": 0.5,
                            "text": "However, research suggests that primary care physicians can accurately diagnose dementia or cognitive impairment in symptomatic individuals with a moderate to high degree of accuracy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 394,
                            "end": 659,
                            "score": 0.5,
                            "text": "A systematic review and meta-analysis published in the journal PLOS Medicine in 2018 found that the pooled sensitivity of primary care physicians' clinical judgment for dementia diagnosis was 73% (95% CI: 64-82%) and the pooled specificity was 86% (95% CI: 79-93%).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 660,
                            "end": 815,
                            "score": 0.5,
                            "text": "However, the review also noted that the quality of the studies included was generally low and that there was significant heterogeneity between the studies.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 816,
                            "end": 1049,
                            "score": 0.5,
                            "text": "Another study published in the Journal of General Internal Medicine in 2016 found that primary care physicians accurately diagnosed dementia in 81.1% of cases, but that the accuracy was lower for milder forms of cognitive impairment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1050,
                            "end": 1328,
                            "score": 0.5,
                            "text": "It's important to note that the accuracy of clinical judgment can be influenced by various factors, such as the physician's experience and training, the quality of the clinical evaluation, and the presence of comorbidities or other conditions that can affect cognitive function.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1329,
                            "end": 1630,
                            "score": 0.5,
                            "text": "Additionally, the diagnosis of dementia or cognitive impairment often requires a comprehensive evaluation, including a thorough medical history, physical examination, laboratory tests, and cognitive assessments, so the accuracy of the diagnosis may be higher when a multidisciplinary team is involved.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4064_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1631,
                            "end": 1958,
                            "score": 0.5,
                            "text": "In summary, while the accuracy of clinical judgment by primary care physicians for the diagnosis of dementia or cognitive impairment can be moderate to high, it's important to consider the limitations of clinical judgment and the importance of a comprehensive evaluation to ensure accurate diagnosis and appropriate management.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4273",
            "question": "What are the effects of erythropoiesis\u2010stimulating agents (ESAs) for anemia in adults with chronic kidney disease?",
            "gold_answer": "When ESAs were compared with each other in adults with chronic kidney disease, there may be little to no differences in all\u2010cause or cardiovascular mortality, myocardial infarction, or the development of end\u2010stage kidney disease. The requirement for blood transfusion is probably greater with epoetin alfa than with darbepoetin alfa, and the latter is probably associated with increased risk of stroke compared with placebo. However, the certainty of evidence is mostly low to very low, and many analyses lacked power to provide reliable results. Trials that compared ESAs with placebo, an alternative ESA, or a biosimilar ESA in adults with chronic kidney disease were combined in network meta\u2010analyses (direct comparisons and indirect comparisons via common comparators). Many of the comparisons were evaluated in very few participants. Of 77 trials, 47 included people undergoing dialysis, and eight included kidney transplant recipients; 22 trials reported estimated glomerular filtration rates between 15 and 90 mL/min/1.73 m\u00b2. Fewer people required blood transfusions with epoetin alfa, epoetin beta and darbepoetin alfa compared with placebo. When ESAs were compared with each other, epoetin alfa increased the risk of blood transfusion compared with darbepoetin alfa Only four of the standard pairwise meta\u2010analyses had sufficient participants to make them relatively well\u2010powered and results were consistent with the network meta\u2010analysis. The evidence for the comparisons darbepoetin alfa versus placebo and epoetin alfa versus darbepoetin alfa was of moderate certainty; the evidence for all other comparisons was of very low to low certainty. Both the network meta\u2010analysis and standard pairwise meta\u2010analysis showed that the incidence of stroke is probably increased with darbepoetin alfa compared with placebo. There may be little to no differences in incidence of stroke for any other ESA compared with placebo, or when ESAs were compared with each other, in either the network or standard pairwise meta\u2010analyses. Neither analysis suggested differences between ESAs and placebo or each other in terms of mortality (all\u2010cause or cardiovascular), myocardial infarction, or end\u2010stage kidney disease.",
            "gold_answer_terms": "CHRONIC (chronic): continuing for a long time, ongoing\nKIDNEY (kidney): The body\u2019s two kidneys keep fluids balanced by filtering the blood. Waste products are then excreted as urine.\nDISEASE (disease): An abnormal condition in the body causing harm.\nMORTALITY (mortality): death\nMYOCARDIAL (myocardial): pertaining to the heart muscle\nINFARCT (infarct): death of tissue due to lack of blood supply\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nTERM (term): Between 37 and 42 weeks of pregnancy.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4273",
            "llm_answer": "Erythropoiesis-stimulating agents (ESAs) are commonly used to treat anemia in adults with chronic kidney disease (CKD). The effects of ESAs include:\n1. Increased hemoglobin levels: ESAs stimulate the production of red blood cells, which increases hemoglobin levels and helps to alleviate anemia.\n2. Improved quality of life: By reducing the severity of anemia, ESAs can improve patients' quality of life, including their ability to perform daily activities and exercise.\n3. Reduced need for blood transfusions: ESAs can reduce the need for blood transfusions, which can help to avoid the risks associated with transfusions, such as infection and blood-borne diseases.\n4. Increased risk of hypertension: ESAs can increase blood pressure, which can be a concern for patients with CKD who are already at risk of developing hypertension.\n5. Increased risk of cardiovascular events: Some studies have suggested that ESAs may increase the risk of cardiovascular events, such as heart attacks and strokes, in patients with CKD.\n6. Increased risk of thrombotic events: ESAs can increase the risk of thrombotic events, such as deep vein thrombosis and pulmonary embolism, in patients with CKD.\n7. Potential for overcorrection: ESAs can overcorrect anemia, leading to high hemoglobin levels, which can increase the risk of cardiovascular and thrombotic events.\n8. Potential for resistance: Some patients may develop resistance to ESAs over time, reducing their effectiveness.\n9. Potential for interaction with other medications: ESAs can interact with other medications, such as blood thinners, and affect their efficacy or increase the risk of adverse events.\nIt's important to note that the use of ESAs in CKD patients is carefully individualized and monitored by healthcare providers to minimize the risks and maximize the benefits. Regular monitoring of hemoglobin levels, blood pressure, and other factors is necessary to ensure safe and effective treatment.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> What are the effects of erythropoiesis\u2010stimulating agents (ESAs) for anemia in adults with chronic kidney disease?[/INST]",
            "topic1": [
                "kidney disease"
            ],
            "topic2": [],
            "year": 2023,
            "author": "Tort, Sera; Ciapponi, Agust\u00edn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 119,
                            "score": 0.5,
                            "text": "Erythropoiesis-stimulating agents (ESAs) are commonly used to treat anemia in adults with chronic kidney disease (CKD).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 120,
                            "end": 148,
                            "score": 0.5,
                            "text": "The effects of ESAs include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 152,
                            "end": 295,
                            "score": 0.5,
                            "text": "Increased hemoglobin levels: ESAs stimulate the production of red blood cells, which increases hemoglobin levels and helps to alleviate anemia.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 299,
                            "end": 470,
                            "score": 0.5,
                            "text": "Improved quality of life: By reducing the severity of anemia, ESAs can improve patients' quality of life, including their ability to perform daily activities and exercise.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 474,
                            "end": 667,
                            "score": 0.5,
                            "text": "Reduced need for blood transfusions: ESAs can reduce the need for blood transfusions, which can help to avoid the risks associated with transfusions, such as infection and blood-borne diseases.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 671,
                            "end": 833,
                            "score": 0.5,
                            "text": "Increased risk of hypertension: ESAs can increase blood pressure, which can be a concern for patients with CKD who are already at risk of developing hypertension.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 837,
                            "end": 1020,
                            "score": 0.5,
                            "text": "Increased risk of cardiovascular events: Some studies have suggested that ESAs may increase the risk of cardiovascular events, such as heart attacks and strokes, in patients with CKD.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1024,
                            "end": 1184,
                            "score": 0.5,
                            "text": "Increased risk of thrombotic events: ESAs can increase the risk of thrombotic events, such as deep vein thrombosis and pulmonary embolism, in patients with CKD.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1188,
                            "end": 1350,
                            "score": 0.5,
                            "text": "Potential for overcorrection: ESAs can overcorrect anemia, leading to high hemoglobin levels, which can increase the risk of cardiovascular and thrombotic events.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1354,
                            "end": 1465,
                            "score": 0.5,
                            "text": "Potential for resistance: Some patients may develop resistance to ESAs over time, reducing their effectiveness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1469,
                            "end": 1650,
                            "score": 0.5,
                            "text": "Potential for interaction with other medications: ESAs can interact with other medications, such as blood thinners, and affect their efficacy or increase the risk of adverse events.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1651,
                            "end": 1825,
                            "score": 0.5,
                            "text": "It's important to note that the use of ESAs in CKD patients is carefully individualized and monitored by healthcare providers to minimize the risks and maximize the benefits.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt0_answer_sent12",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1826,
                            "end": 1953,
                            "score": 0.5,
                            "text": "Regular monitoring of hemoglobin levels, blood pressure, and other factors is necessary to ensure safe and effective treatment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4273",
            "question": "What are the effects of erythropoiesis\u2010stimulating agents (ESAs) for anemia in adults with chronic kidney disease?",
            "gold_answer": "When ESAs were compared with each other in adults with chronic kidney disease, there may be little to no differences in all\u2010cause or cardiovascular mortality, myocardial infarction, or the development of end\u2010stage kidney disease. The requirement for blood transfusion is probably greater with epoetin alfa than with darbepoetin alfa, and the latter is probably associated with increased risk of stroke compared with placebo. However, the certainty of evidence is mostly low to very low, and many analyses lacked power to provide reliable results. Trials that compared ESAs with placebo, an alternative ESA, or a biosimilar ESA in adults with chronic kidney disease were combined in network meta\u2010analyses (direct comparisons and indirect comparisons via common comparators). Many of the comparisons were evaluated in very few participants. Of 77 trials, 47 included people undergoing dialysis, and eight included kidney transplant recipients; 22 trials reported estimated glomerular filtration rates between 15 and 90 mL/min/1.73 m\u00b2. Fewer people required blood transfusions with epoetin alfa, epoetin beta and darbepoetin alfa compared with placebo. When ESAs were compared with each other, epoetin alfa increased the risk of blood transfusion compared with darbepoetin alfa Only four of the standard pairwise meta\u2010analyses had sufficient participants to make them relatively well\u2010powered and results were consistent with the network meta\u2010analysis. The evidence for the comparisons darbepoetin alfa versus placebo and epoetin alfa versus darbepoetin alfa was of moderate certainty; the evidence for all other comparisons was of very low to low certainty. Both the network meta\u2010analysis and standard pairwise meta\u2010analysis showed that the incidence of stroke is probably increased with darbepoetin alfa compared with placebo. There may be little to no differences in incidence of stroke for any other ESA compared with placebo, or when ESAs were compared with each other, in either the network or standard pairwise meta\u2010analyses. Neither analysis suggested differences between ESAs and placebo or each other in terms of mortality (all\u2010cause or cardiovascular), myocardial infarction, or end\u2010stage kidney disease.",
            "gold_answer_terms": "CHRONIC (chronic): continuing for a long time, ongoing\nKIDNEY (kidney): The body\u2019s two kidneys keep fluids balanced by filtering the blood. Waste products are then excreted as urine.\nDISEASE (disease): An abnormal condition in the body causing harm.\nMORTALITY (mortality): death\nMYOCARDIAL (myocardial): pertaining to the heart muscle\nINFARCT (infarct): death of tissue due to lack of blood supply\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nTERM (term): Between 37 and 42 weeks of pregnancy.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4273",
            "llm_answer": "Erythropoiesis-stimulating agents (ESAs) are medications that stimulate the production of red blood cells in the body. They are commonly used to treat anemia in adults with chronic kidney disease (CKD), as anemia is a common complication of CKD.\nThe effects of ESAs for anemia in adults with CKD include:\n1. Increased red blood cell count: ESAs stimulate the production of red blood cells, which can help to increase the red blood cell count in the body. This can help to improve symptoms such as fatigue, weakness, and shortness of breath.\n2. Improved quality of life: By increasing the red blood cell count, ESAs can help to improve a patient's quality of life, as they may feel more energetic and able to perform daily activities with greater ease.\n3. Reduced need for blood transfusions: ESAs can help to reduce the need for blood transfusions, which can be beneficial for patients who may have concerns about receiving blood products or who have had negative experiences with blood transfusions in the past.\n4. Potential risks: While ESAs can be effective in treating anemia in CKD patients, there are potential risks associated with their use. These risks include an increased risk of blood clots, high blood pressure, and stroke. It is important for patients to discuss the potential risks and benefits of ESAs with their healthcare provider before starting treatment.\nIt is important to note that ESAs should only be used under the guidance of a healthcare provider, as they can monitor the patient's response to treatment and adjust the dosage as needed. Additionally, patients with CKD should be monitored regularly for signs of iron deficiency, as iron is necessary for the production of red blood cells.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> What are the effects of erythropoiesis\u2010stimulating agents (ESAs) for anemia in adults with chronic kidney disease?[/INST]",
            "topic1": [
                "kidney disease"
            ],
            "topic2": [],
            "year": 2023,
            "author": "Tort, Sera; Ciapponi, Agust\u00edn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 118,
                            "score": 0.5,
                            "text": "Erythropoiesis-stimulating agents (ESAs) are medications that stimulate the production of red blood cells in the body.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 119,
                            "end": 245,
                            "score": 0.5,
                            "text": "They are commonly used to treat anemia in adults with chronic kidney disease (CKD), as anemia is a common complication of CKD.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 246,
                            "end": 304,
                            "score": 0.5,
                            "text": "The effects of ESAs for anemia in adults with CKD include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 308,
                            "end": 454,
                            "score": 0.5,
                            "text": "Increased red blood cell count: ESAs stimulate the production of red blood cells, which can help to increase the red blood cell count in the body.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 455,
                            "end": 540,
                            "score": 0.5,
                            "text": "This can help to improve symptoms such as fatigue, weakness, and shortness of breath.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 544,
                            "end": 751,
                            "score": 0.5,
                            "text": "Improved quality of life: By increasing the red blood cell count, ESAs can help to improve a patient's quality of life, as they may feel more energetic and able to perform daily activities with greater ease.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 755,
                            "end": 1012,
                            "score": 0.5,
                            "text": "Reduced need for blood transfusions: ESAs can help to reduce the need for blood transfusions, which can be beneficial for patients who may have concerns about receiving blood products or who have had negative experiences with blood transfusions in the past.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1016,
                            "end": 1149,
                            "score": 0.5,
                            "text": "Potential risks: While ESAs can be effective in treating anemia in CKD patients, there are potential risks associated with their use.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1150,
                            "end": 1236,
                            "score": 0.5,
                            "text": "These risks include an increased risk of blood clots, high blood pressure, and stroke.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1237,
                            "end": 1375,
                            "score": 0.5,
                            "text": "It is important for patients to discuss the potential risks and benefits of ESAs with their healthcare provider before starting treatment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1376,
                            "end": 1563,
                            "score": 0.5,
                            "text": "It is important to note that ESAs should only be used under the guidance of a healthcare provider, as they can monitor the patient's response to treatment and adjust the dosage as needed.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4273_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1564,
                            "end": 1715,
                            "score": 0.5,
                            "text": "Additionally, patients with CKD should be monitored regularly for signs of iron deficiency, as iron is necessary for the production of red blood cells.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3559",
            "question": "For adults with progression or recurrence of glioblastoma, how do treatment options compare?",
            "gold_answer": "Network meta\u2010analyses (NMAs) suggest regorafenib may be superior to other treatment options in terms of overall survival for people with progression or recurrence of glioblastoma. However, the networks omit several treatment options, and results for many comparisons are imprecise. Consequently, available evidence is insufficient to draw firm conclusions. Reviewers performed NMAs comparing treatment options for adults with progression or recurrence of glioblastoma. The NMAs included different treatment options, reporting different outcomes. Several treatment options were omitted from all NMAs. One NMA suggested that overall survival may be better with regorafenib than with eight of the 10 other active comparisons (no clear difference with regorafenib versus ABT414 plus temozolomide, or regorafenib versus fotemustine). The certainty of the evidence ranged from moderate to very low across comparisons. In six of 10 active comparisons, better overall survival was reported with the alternative regimen than with ABT414 plus temozolomide (no clear difference between ABT414 plus temozolomide and fotemustine or regorafenib; ABT414 plus temozolomide seemed to have better survival than lomustine or ABT414 alone). This NMA was restricted to trials reporting first recurrence; median survival time across these trials ranged from 5.5 months to 12.6 months. Median survival times across all trials reporting overall survival ranged from one month to 18.3 months. The NMA of progression\u2010free survival (PFS) produced results that were imprecise for most comparisons. The certainty of the evidence ranged from moderate to very low across comparisons. Bevacizumab plus lomustine appeared to have better PFS than bevacizumab or lomustine alone, and regorafenib better PFS than lomustine. This NMA was also restricted to trials reporting first recurrence; median survival time across these trials ranged from 1.5 months to 4.2 months. Median PFS times across all trials reporting this outcome ranged from one month to 15 months for first recurrence, and from 0.7 months to 5.6 months for any first or subsequent recurrence. In terms of severe adverse events (SAEs), reviewers performed two NMAs \u2013 one of eight bevacizumab trials and one of six lomustine trials. The certainty of the evidence ranged from moderate to very low across comparisons. Results of the former showed bevacizumab plus TRC105 had fewer SAEs than seven other active treatments (no clear difference compared with bevacizumab plus VB\u2010111) and bevacizumab plus VB\u2010111 had fewer SAEs than six other active treatments (no clear difference compared with bevacizumab plus TRC105 or irinotecan). Results from the latter showed bevacizumab or cediranib plus lomustine had fewer SAEs than lomustine or cediranib alone, and regorafenib had fewer SAEs than lomustine. Results for other comparisons were imprecise. Reviewers did not report absolute numbers of SAEs for all trials reporting this outcome.",
            "gold_answer_terms": "TERM (term): Between 37 and 42 weeks of pregnancy.\nREGIMEN (regimen): pattern of giving treatment",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3559",
            "llm_answer": "For adults with progression or recurrence of glioblastoma, treatment options may include:\n1. Surgery: Surgical removal of the tumor is often the first line of treatment, followed by radiation therapy and chemotherapy.\n2. Radiation therapy: External beam radiation therapy (EBRT) and stereotactic radiosurgery (SRS) are common treatment options.\n3. Chemotherapy: Temozolomide is a commonly used chemotherapy drug, often used in combination with other drugs.\n4. Targeted therapy: Bevacizumab, a monoclonal antibody that targets vascular endothelial growth factor (VEGF), is sometimes used to slow tumor growth.\n5. Immunotherapy: Checkpoint inhibitors, such as pembrolizumab and nivolumab, have shown promise in clinical trials.\n6. Clinical trials: Participation in clinical trials may provide access to new and innovative treatments.\nIt's important to note that the most appropriate treatment plan will depend on various factors, including the patient's overall health, tumor size and location, and previous treatment history. It's important to discuss the best treatment options with a qualified healthcare professional.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For adults with progression or recurrence of glioblastoma, how do treatment options compare?[/INST]",
            "topic1": [
                "cancers",
                "neurology"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Burch, Jane; Goodden, John"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 89,
                            "score": 0.5,
                            "text": "For adults with progression or recurrence of glioblastoma, treatment options may include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 93,
                            "end": 217,
                            "score": 0.5,
                            "text": "Surgery: Surgical removal of the tumor is often the first line of treatment, followed by radiation therapy and chemotherapy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 221,
                            "end": 344,
                            "score": 0.5,
                            "text": "Radiation therapy: External beam radiation therapy (EBRT) and stereotactic radiosurgery (SRS) are common treatment options.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 348,
                            "end": 456,
                            "score": 0.5,
                            "text": "Chemotherapy: Temozolomide is a commonly used chemotherapy drug, often used in combination with other drugs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 460,
                            "end": 608,
                            "score": 0.5,
                            "text": "Targeted therapy: Bevacizumab, a monoclonal antibody that targets vascular endothelial growth factor (VEGF), is sometimes used to slow tumor growth.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 612,
                            "end": 725,
                            "score": 0.5,
                            "text": "Immunotherapy: Checkpoint inhibitors, such as pembrolizumab and nivolumab, have shown promise in clinical trials.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 729,
                            "end": 831,
                            "score": 0.5,
                            "text": "Clinical trials: Participation in clinical trials may provide access to new and innovative treatments.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 832,
                            "end": 1024,
                            "score": 0.5,
                            "text": "It's important to note that the most appropriate treatment plan will depend on various factors, including the patient's overall health, tumor size and location, and previous treatment history.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt0_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1025,
                            "end": 1119,
                            "score": 0.5,
                            "text": "It's important to discuss the best treatment options with a qualified healthcare professional.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3559",
            "question": "For adults with progression or recurrence of glioblastoma, how do treatment options compare?",
            "gold_answer": "Network meta\u2010analyses (NMAs) suggest regorafenib may be superior to other treatment options in terms of overall survival for people with progression or recurrence of glioblastoma. However, the networks omit several treatment options, and results for many comparisons are imprecise. Consequently, available evidence is insufficient to draw firm conclusions. Reviewers performed NMAs comparing treatment options for adults with progression or recurrence of glioblastoma. The NMAs included different treatment options, reporting different outcomes. Several treatment options were omitted from all NMAs. One NMA suggested that overall survival may be better with regorafenib than with eight of the 10 other active comparisons (no clear difference with regorafenib versus ABT414 plus temozolomide, or regorafenib versus fotemustine). The certainty of the evidence ranged from moderate to very low across comparisons. In six of 10 active comparisons, better overall survival was reported with the alternative regimen than with ABT414 plus temozolomide (no clear difference between ABT414 plus temozolomide and fotemustine or regorafenib; ABT414 plus temozolomide seemed to have better survival than lomustine or ABT414 alone). This NMA was restricted to trials reporting first recurrence; median survival time across these trials ranged from 5.5 months to 12.6 months. Median survival times across all trials reporting overall survival ranged from one month to 18.3 months. The NMA of progression\u2010free survival (PFS) produced results that were imprecise for most comparisons. The certainty of the evidence ranged from moderate to very low across comparisons. Bevacizumab plus lomustine appeared to have better PFS than bevacizumab or lomustine alone, and regorafenib better PFS than lomustine. This NMA was also restricted to trials reporting first recurrence; median survival time across these trials ranged from 1.5 months to 4.2 months. Median PFS times across all trials reporting this outcome ranged from one month to 15 months for first recurrence, and from 0.7 months to 5.6 months for any first or subsequent recurrence. In terms of severe adverse events (SAEs), reviewers performed two NMAs \u2013 one of eight bevacizumab trials and one of six lomustine trials. The certainty of the evidence ranged from moderate to very low across comparisons. Results of the former showed bevacizumab plus TRC105 had fewer SAEs than seven other active treatments (no clear difference compared with bevacizumab plus VB\u2010111) and bevacizumab plus VB\u2010111 had fewer SAEs than six other active treatments (no clear difference compared with bevacizumab plus TRC105 or irinotecan). Results from the latter showed bevacizumab or cediranib plus lomustine had fewer SAEs than lomustine or cediranib alone, and regorafenib had fewer SAEs than lomustine. Results for other comparisons were imprecise. Reviewers did not report absolute numbers of SAEs for all trials reporting this outcome.",
            "gold_answer_terms": "TERM (term): Between 37 and 42 weeks of pregnancy.\nREGIMEN (regimen): pattern of giving treatment",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3559",
            "llm_answer": "For adults with progression or recurrence of glioblastoma, treatment options may vary depending on various factors, such as the location and size of the tumor, overall health status, and patient preferences. Here are some possible treatment options that may be considered:\n1. Surgery: Surgery may be recommended to remove as much of the tumor as possible, followed by radiation therapy and/or chemotherapy to treat any remaining cancer cells.\n2. Radiation therapy: Radiation therapy uses high-energy beams to kill cancer cells. It may be used alone or in combination with surgery or chemotherapy.\n3. Chemotherapy: Chemotherapy uses drugs to kill cancer cells. It may be given orally or intravenously, and may be used alone or in combination with surgery or radiation therapy.\n4. Targeted therapy: Targeted therapy uses drugs to target specific molecules that promote cancer growth and progression. Bevacizumab is an example of a targeted therapy that may be used for glioblastoma.\n5. Immunotherapy: Immunotherapy uses the body's immune system to fight cancer. It may be used alone or in combination with other treatments.\n6. Clinical trials: Clinical trials are research studies that evaluate new treatments for glioblastoma. Participating in a clinical trial may provide access to new and innovative treatments that are not yet widely available.\nIt's important to note that the most effective treatment plan for glioblastoma often involves a combination of different therapies, and may require a multidisciplinary approach involving neurosurgeons, radiation oncologists, medical oncologists, and other healthcare professionals. Patients should discuss their treatment options with their healthcare team and consider their individual circumstances and preferences when making decisions about their care.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For adults with progression or recurrence of glioblastoma, how do treatment options compare?[/INST]",
            "topic1": [
                "cancers",
                "neurology"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Burch, Jane; Goodden, John"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 207,
                            "score": 0.5,
                            "text": "For adults with progression or recurrence of glioblastoma, treatment options may vary depending on various factors, such as the location and size of the tumor, overall health status, and patient preferences.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 208,
                            "end": 272,
                            "score": 0.5,
                            "text": "Here are some possible treatment options that may be considered:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 276,
                            "end": 442,
                            "score": 0.5,
                            "text": "Surgery: Surgery may be recommended to remove as much of the tumor as possible, followed by radiation therapy and/or chemotherapy to treat any remaining cancer cells.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 446,
                            "end": 527,
                            "score": 0.5,
                            "text": "Radiation therapy: Radiation therapy uses high-energy beams to kill cancer cells.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 528,
                            "end": 596,
                            "score": 0.5,
                            "text": "It may be used alone or in combination with surgery or chemotherapy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 600,
                            "end": 659,
                            "score": 0.5,
                            "text": "Chemotherapy: Chemotherapy uses drugs to kill cancer cells.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 660,
                            "end": 775,
                            "score": 0.5,
                            "text": "It may be given orally or intravenously, and may be used alone or in combination with surgery or radiation therapy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 779,
                            "end": 897,
                            "score": 0.5,
                            "text": "Targeted therapy: Targeted therapy uses drugs to target specific molecules that promote cancer growth and progression.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 898,
                            "end": 980,
                            "score": 0.5,
                            "text": "Bevacizumab is an example of a targeted therapy that may be used for glioblastoma.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 984,
                            "end": 1059,
                            "score": 0.5,
                            "text": "Immunotherapy: Immunotherapy uses the body's immune system to fight cancer.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1060,
                            "end": 1121,
                            "score": 0.5,
                            "text": "It may be used alone or in combination with other treatments.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1125,
                            "end": 1225,
                            "score": 0.5,
                            "text": "Clinical trials: Clinical trials are research studies that evaluate new treatments for glioblastoma.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent12",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1226,
                            "end": 1346,
                            "score": 0.5,
                            "text": "Participating in a clinical trial may provide access to new and innovative treatments that are not yet widely available.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent13",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1347,
                            "end": 1628,
                            "score": 0.5,
                            "text": "It's important to note that the most effective treatment plan for glioblastoma often involves a combination of different therapies, and may require a multidisciplinary approach involving neurosurgeons, radiation oncologists, medical oncologists, and other healthcare professionals.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3559_llama2_70b_chat_prompt1_answer_sent14",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1629,
                            "end": 1803,
                            "score": 0.5,
                            "text": "Patients should discuss their treatment options with their healthcare team and consider their individual circumstances and preferences when making decisions about their care.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3670",
            "question": "What are the benefits and harms of interventions to increase patient and family involvement in the escalation of care for community health and hospital settings?",
            "gold_answer": "For adults and children with acute life\u2010threatening illnesses in community health and hospital settings, low\u2010certainty evidence suggests that interventions to increase patient and family involvement in the escalation of care may moderately improve patient and family involvement and knowledge about symptoms, appropriate responses, and preparedness capacity. These interventions may improve patient and family self\u2010efficacy (1 out of 2 studies suggests slight improvement) and may result in little to no difference in improving time to treatment (3 studies found little to no difference between groups, and only 1 study reported modest benefit). Reviewers found no RCTs evaluating patient and family perceptions or satisfaction with care.",
            "gold_answer_terms": "ACUTE (acute): new, recent, sudden, urgent\nSYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nRCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3670",
            "llm_answer": "Benefits of interventions to increase patient and family involvement in the escalation of care for community health and hospital settings include:\n* Improved patient outcomes and satisfaction\n* Enhanced communication and collaboration between patients, families, and healthcare providers\n* Increased patient empowerment and engagement in their own care\n* Reduced medical errors and adverse events\n* More efficient and effective care\nHarms of interventions to increase patient and family involvement in the escalation of care may include:\n* Increased burden and stress on patients and families\n* Potential for misunderstandings or miscommunications\n* Difficulty in navigating complex healthcare systems\n* Potential for conflicts between patients, families, and healthcare providers\n* Increased costs associated with patient and family involvement.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> What are the benefits and harms of interventions to increase patient and family involvement in the escalation of care for community health and hospital settings?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Ciapponi, Agust\u00edn; Eti, Serife"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 146,
                            "score": 0.5,
                            "text": "Benefits of interventions to increase patient and family involvement in the escalation of care for community health and hospital settings include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 147,
                            "end": 191,
                            "score": 0.5,
                            "text": "* Improved patient outcomes and satisfaction",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 192,
                            "end": 287,
                            "score": 0.5,
                            "text": "* Enhanced communication and collaboration between patients, families, and healthcare providers",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 288,
                            "end": 352,
                            "score": 0.5,
                            "text": "* Increased patient empowerment and engagement in their own care",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 353,
                            "end": 396,
                            "score": 0.5,
                            "text": "* Reduced medical errors and adverse events",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 397,
                            "end": 432,
                            "score": 0.5,
                            "text": "* More efficient and effective care",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 433,
                            "end": 537,
                            "score": 0.5,
                            "text": "Harms of interventions to increase patient and family involvement in the escalation of care may include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 538,
                            "end": 592,
                            "score": 0.5,
                            "text": "* Increased burden and stress on patients and families",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 593,
                            "end": 647,
                            "score": 0.5,
                            "text": "* Potential for misunderstandings or miscommunications",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 648,
                            "end": 701,
                            "score": 0.5,
                            "text": "* Difficulty in navigating complex healthcare systems",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 702,
                            "end": 780,
                            "score": 0.5,
                            "text": "* Potential for conflicts between patients, families, and healthcare providers",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt0_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 781,
                            "end": 846,
                            "score": 0.5,
                            "text": "* Increased costs associated with patient and family involvement.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3670",
            "question": "What are the benefits and harms of interventions to increase patient and family involvement in the escalation of care for community health and hospital settings?",
            "gold_answer": "For adults and children with acute life\u2010threatening illnesses in community health and hospital settings, low\u2010certainty evidence suggests that interventions to increase patient and family involvement in the escalation of care may moderately improve patient and family involvement and knowledge about symptoms, appropriate responses, and preparedness capacity. These interventions may improve patient and family self\u2010efficacy (1 out of 2 studies suggests slight improvement) and may result in little to no difference in improving time to treatment (3 studies found little to no difference between groups, and only 1 study reported modest benefit). Reviewers found no RCTs evaluating patient and family perceptions or satisfaction with care.",
            "gold_answer_terms": "ACUTE (acute): new, recent, sudden, urgent\nSYMPTOM (symptom): A specific medical sign of a condition, illness or disease.\nRCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3670",
            "llm_answer": "Interventions aimed at increasing patient and family involvement in the escalation of care can have several benefits in both community health and hospital settings. Some of the benefits include:\nBenefits in Community Health Settings:\n1. Improved patient outcomes: By involving patients and their families in the escalation of care, they can receive timely and appropriate interventions, leading to better health outcomes.\n2. Enhanced patient engagement: Patients and families are more likely to be invested in their care when they are involved in the decision-making process, leading to increased patient engagement and empowerment.\n3. Better care coordination: Patient and family involvement can facilitate communication and collaboration among healthcare providers, leading to better care coordination and reduced risk of medical errors.\n4. Increased patient satisfaction: When patients and their families are involved in their care, they are more likely to feel satisfied with their healthcare experience.\nBenefits in Hospital Settings:\n1. Improved patient safety: By involving patients and their families in the escalation of care, hospitals can reduce the risk of medical errors and adverse events.\n2. Reduced length of stay: When patients and their families are involved in the escalation of care, they can help identify potential issues earlier, leading to earlier interventions and reduced length of stay.\n3. Improved patient experience: Patient and family involvement can lead to improved patient satisfaction and a more positive hospital experience.\n4. Increased patient loyalty: When patients and their families feel involved and empowered, they are more likely to return to the hospital for future care and recommend it to others.\nHowever, there are also potential harms associated with interventions aimed at increasing patient and family involvement in the escalation of care. Some of the harms include:\nHarms in Community Health Settings:\n1. Information overload: Providing patients and families with too much information can lead to information overload, causing confusion and anxiety.\n2. Unrealistic expectations: Patients and families may have unrealistic expectations about the benefits of escalation, leading to disappointment and frustration.\n3. Increased burden: Involving patients and families in the",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> What are the benefits and harms of interventions to increase patient and family involvement in the escalation of care for community health and hospital settings?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Ciapponi, Agust\u00edn; Eti, Serife"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 164,
                            "score": 0.5,
                            "text": "Interventions aimed at increasing patient and family involvement in the escalation of care can have several benefits in both community health and hospital settings.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 165,
                            "end": 194,
                            "score": 0.5,
                            "text": "Some of the benefits include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 195,
                            "end": 233,
                            "score": 0.5,
                            "text": "Benefits in Community Health Settings:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 237,
                            "end": 421,
                            "score": 0.5,
                            "text": "Improved patient outcomes: By involving patients and their families in the escalation of care, they can receive timely and appropriate interventions, leading to better health outcomes.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 425,
                            "end": 632,
                            "score": 0.5,
                            "text": "Enhanced patient engagement: Patients and families are more likely to be invested in their care when they are involved in the decision-making process, leading to increased patient engagement and empowerment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 636,
                            "end": 839,
                            "score": 0.5,
                            "text": "Better care coordination: Patient and family involvement can facilitate communication and collaboration among healthcare providers, leading to better care coordination and reduced risk of medical errors.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 843,
                            "end": 1008,
                            "score": 0.5,
                            "text": "Increased patient satisfaction: When patients and their families are involved in their care, they are more likely to feel satisfied with their healthcare experience.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1009,
                            "end": 1039,
                            "score": 0.5,
                            "text": "Benefits in Hospital Settings:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1043,
                            "end": 1203,
                            "score": 0.5,
                            "text": "Improved patient safety: By involving patients and their families in the escalation of care, hospitals can reduce the risk of medical errors and adverse events.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1207,
                            "end": 1413,
                            "score": 0.5,
                            "text": "Reduced length of stay: When patients and their families are involved in the escalation of care, they can help identify potential issues earlier, leading to earlier interventions and reduced length of stay.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1417,
                            "end": 1559,
                            "score": 0.5,
                            "text": "Improved patient experience: Patient and family involvement can lead to improved patient satisfaction and a more positive hospital experience.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1563,
                            "end": 1742,
                            "score": 0.5,
                            "text": "Increased patient loyalty: When patients and their families feel involved and empowered, they are more likely to return to the hospital for future care and recommend it to others.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent12",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1743,
                            "end": 1890,
                            "score": 0.5,
                            "text": "However, there are also potential harms associated with interventions aimed at increasing patient and family involvement in the escalation of care.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent13",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1891,
                            "end": 1917,
                            "score": 0.5,
                            "text": "Some of the harms include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent14",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1918,
                            "end": 1953,
                            "score": 0.5,
                            "text": "Harms in Community Health Settings:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent15",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1957,
                            "end": 2101,
                            "score": 0.5,
                            "text": "Information overload: Providing patients and families with too much information can lead to information overload, causing confusion and anxiety.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent16",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 2105,
                            "end": 2263,
                            "score": 0.5,
                            "text": "Unrealistic expectations: Patients and families may have unrealistic expectations about the benefits of escalation, leading to disappointment and frustration.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3670_llama2_70b_chat_prompt1_answer_sent17",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 2267,
                            "end": 2323,
                            "score": 0.5,
                            "text": "Increased burden: Involving patients and families in the",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3365",
            "question": "How does hospital\u2010based specialist palliative care (HSPC) affect adults with advanced illness?",
            "gold_answer": "For adults with advanced illness, evidence suggests that HSPC (intervention components included symptom control, decision\u2010making, future planning, coping/support, and care co\u2010ordination) may have several beneficial effects when compared with usual care (poorly described and variable across trial), including improvements in quality of life, symptom burden, depression scores, and pain scores; however, differences detected between HSPC and usual care for these outcomes were often small, and evidence was rated as low to very low certainty. Other benefits of HSPC may include a decrease in the number of people suffering with depression (on average, 192 vs 383 per 1000 people; based on 338 participants) and an increase in the number of people who achieve death at home (on average, 598 vs 478 per 1000 people; low\u2010certainty evidence). Participants also appear to be more satisfied with HSPC than with usual care (low\u2010certainty evidence). Given the low quality of available evidence, no firm conclusions can be drawn.",
            "gold_answer_terms": "SYMPTOM (symptom): A specific medical sign of a condition, illness or disease.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3365",
            "llm_answer": "Hospital-based specialist palliative care (HSPC) has been shown to improve the quality of life, symptom management, and end-of-life care for adults with advanced illness. Studies have found that HSPC can lead to improved patient satisfaction, reduced hospital readmissions, and increased use of advance care planning. Additionally, HSPC can provide emotional and spiritual support to patients and their families, helping them cope with the challenges of serious illness. Overall, HSPC can play a crucial role in ensuring that adults with advanced illness receive comprehensive and compassionate care that addresses their physical, emotional, and social needs.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How does hospital\u2010based specialist palliative care (HSPC) affect adults with advanced illness?[/INST]",
            "topic1": [
                "cancers"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Gupta, Adarsh"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 170,
                            "score": 0.5,
                            "text": "Hospital-based specialist palliative care (HSPC) has been shown to improve the quality of life, symptom management, and end-of-life care for adults with advanced illness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 171,
                            "end": 317,
                            "score": 0.5,
                            "text": "Studies have found that HSPC can lead to improved patient satisfaction, reduced hospital readmissions, and increased use of advance care planning.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 318,
                            "end": 470,
                            "score": 0.5,
                            "text": "Additionally, HSPC can provide emotional and spiritual support to patients and their families, helping them cope with the challenges of serious illness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 471,
                            "end": 659,
                            "score": 0.5,
                            "text": "Overall, HSPC can play a crucial role in ensuring that adults with advanced illness receive comprehensive and compassionate care that addresses their physical, emotional, and social needs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3365",
            "question": "How does hospital\u2010based specialist palliative care (HSPC) affect adults with advanced illness?",
            "gold_answer": "For adults with advanced illness, evidence suggests that HSPC (intervention components included symptom control, decision\u2010making, future planning, coping/support, and care co\u2010ordination) may have several beneficial effects when compared with usual care (poorly described and variable across trial), including improvements in quality of life, symptom burden, depression scores, and pain scores; however, differences detected between HSPC and usual care for these outcomes were often small, and evidence was rated as low to very low certainty. Other benefits of HSPC may include a decrease in the number of people suffering with depression (on average, 192 vs 383 per 1000 people; based on 338 participants) and an increase in the number of people who achieve death at home (on average, 598 vs 478 per 1000 people; low\u2010certainty evidence). Participants also appear to be more satisfied with HSPC than with usual care (low\u2010certainty evidence). Given the low quality of available evidence, no firm conclusions can be drawn.",
            "gold_answer_terms": "SYMPTOM (symptom): A specific medical sign of a condition, illness or disease.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3365",
            "llm_answer": "Hospital-based specialist palliative care (HSPC) can have a positive impact on adults with advanced illness by providing them with comprehensive and coordinated care that focuses on managing their symptoms, improving their quality of life, and addressing their physical, emotional, social, and spiritual needs. HSPC teams typically consist of interdisciplinary healthcare professionals, including palliative care physicians, nurses, social workers, and chaplains, who work together to develop individualized care plans that align with patients' values, goals, and preferences.\nResearch has shown that HSPC can lead to various benefits for adults with advanced illness, including:\n1. Improved symptom management: HSPC teams are skilled in managing complex symptoms, such as pain, nausea, breathing difficulties, and constipation, which can significantly improve patients' quality of life.\n2. Enhanced communication and coordination: HSPC teams facilitate communication between patients, families, and healthcare providers, ensuring that patients' needs and preferences are respected and addressed. This coordination can also help reduce hospital readmissions and emergency department visits.\n3. Better emotional and psychological support: HSPC teams provide emotional and psychological support to patients and their families, helping them cope with the emotional challenges associated with advanced illness.\n4. Increased patient satisfaction: HSPC teams focus on patient-centered care, which can lead to higher patient satisfaction rates compared to traditional medical care.\n5. Cost-effective care: HSPC can help reduce healthcare costs by avoiding unnecessary hospitalizations, tests, and treatments that may not align with patients' goals or improve their quality of life.\n6. Improved bereavement support: HSPC teams provide support to families and caregivers during the bereavement process, which can help them cope with their loss and navigate the grieving process.\nIt is important to note that HSPC is not the same as hospice care, which is specifically designed for patients with a terminal illness and a life expectancy of six months or less. HSPC can be provided alongside other medical treatments, and it is appropriate for patients with advanced illness who",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How does hospital\u2010based specialist palliative care (HSPC) affect adults with advanced illness?[/INST]",
            "topic1": [
                "cancers"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Gupta, Adarsh"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 310,
                            "score": 0.5,
                            "text": "Hospital-based specialist palliative care (HSPC) can have a positive impact on adults with advanced illness by providing them with comprehensive and coordinated care that focuses on managing their symptoms, improving their quality of life, and addressing their physical, emotional, social, and spiritual needs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 311,
                            "end": 576,
                            "score": 0.5,
                            "text": "HSPC teams typically consist of interdisciplinary healthcare professionals, including palliative care physicians, nurses, social workers, and chaplains, who work together to develop individualized care plans that align with patients' values, goals, and preferences.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 577,
                            "end": 679,
                            "score": 0.5,
                            "text": "Research has shown that HSPC can lead to various benefits for adults with advanced illness, including:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 683,
                            "end": 887,
                            "score": 0.5,
                            "text": "Improved symptom management: HSPC teams are skilled in managing complex symptoms, such as pain, nausea, breathing difficulties, and constipation, which can significantly improve patients' quality of life.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 891,
                            "end": 1096,
                            "score": 0.5,
                            "text": "Enhanced communication and coordination: HSPC teams facilitate communication between patients, families, and healthcare providers, ensuring that patients' needs and preferences are respected and addressed.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1097,
                            "end": 1190,
                            "score": 0.5,
                            "text": "This coordination can also help reduce hospital readmissions and emergency department visits.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1194,
                            "end": 1406,
                            "score": 0.5,
                            "text": "Better emotional and psychological support: HSPC teams provide emotional and psychological support to patients and their families, helping them cope with the emotional challenges associated with advanced illness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1410,
                            "end": 1574,
                            "score": 0.5,
                            "text": "Increased patient satisfaction: HSPC teams focus on patient-centered care, which can lead to higher patient satisfaction rates compared to traditional medical care.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1578,
                            "end": 1774,
                            "score": 0.5,
                            "text": "Cost-effective care: HSPC can help reduce healthcare costs by avoiding unnecessary hospitalizations, tests, and treatments that may not align with patients' goals or improve their quality of life.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1778,
                            "end": 1969,
                            "score": 0.5,
                            "text": "Improved bereavement support: HSPC teams provide support to families and caregivers during the bereavement process, which can help them cope with their loss and navigate the grieving process.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1970,
                            "end": 2149,
                            "score": 0.5,
                            "text": "It is important to note that HSPC is not the same as hospice care, which is specifically designed for patients with a terminal illness and a life expectancy of six months or less.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3365_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 2150,
                            "end": 2267,
                            "score": 0.5,
                            "text": "HSPC can be provided alongside other medical treatments, and it is appropriate for patients with advanced illness who",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3735",
            "question": "How does lacosamide add\u2010on therapy compare with placebo for people with focal epilepsy?",
            "gold_answer": "Although lacosamide reduced seizure frequency for people with treatment\u2010resistant focal epilepsy compared with placebo, there was a concomitant increase in adverse events, particularly at higher doses, some ultimately leading to treatment withdrawal. For people with treatment\u2010resistant simple or complex focal seizures, with or without secondary generalized seizures, high\u2010certainty evidence shows that lacosamide (at 200, 400, or 600 mg daily) increases the number of people with at least 50% reduction in seizure frequency when compared with placebo (389 vs 216 per 1000 people had a 50% reduction; all results on average) but leads to increased treatment withdrawal at all doses (191 vs 122 per 1000 people; moderate\u2010certainty evidence). Ten adverse events seemed more commonly associated with lacosamide when the analysis included all doses (abnormal co\u2010ordination; ataxia; blurred vision; diplopia; dizziness; fatigue; nausea; somnolence; vertigo; vomiting). Abnormal vision showed higher rates with the highest dose (600 mg). Results for serious adverse events were imprecise. All five trials were sponsored by the manufacturers of lacosamide as part of the drug development program.",
            "gold_answer_terms": "PLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nSOMNOLENCE (somnolence): sleepiness",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3735",
            "llm_answer": "Lacosamide add-on therapy has been shown to be effective in reducing seizure frequency in people with focal epilepsy, compared to placebo. In clinical trials, lacosamide has been shown to reduce seizure frequency by 30-50% in patients with focal epilepsy, while placebo has been shown to reduce seizure frequency by 10-20%. Additionally, lacosamide has been shown to have a similar or lower rate of adverse effects compared to placebo. Therefore, lacosamide add-on therapy may be a useful treatment option for patients with focal epilepsy who have not achieved adequate seizure control with other treatments.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How does lacosamide add\u2010on therapy compare with placebo for people with focal epilepsy?[/INST]",
            "topic1": [
                "child health",
                "neurology"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Antonio\u2010Santos, Aileen A."
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 138,
                            "score": 0.5,
                            "text": "Lacosamide add-on therapy has been shown to be effective in reducing seizure frequency in people with focal epilepsy, compared to placebo.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 139,
                            "end": 323,
                            "score": 0.5,
                            "text": "In clinical trials, lacosamide has been shown to reduce seizure frequency by 30-50% in patients with focal epilepsy, while placebo has been shown to reduce seizure frequency by 10-20%.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 324,
                            "end": 435,
                            "score": 0.5,
                            "text": "Additionally, lacosamide has been shown to have a similar or lower rate of adverse effects compared to placebo.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 436,
                            "end": 608,
                            "score": 0.5,
                            "text": "Therefore, lacosamide add-on therapy may be a useful treatment option for patients with focal epilepsy who have not achieved adequate seizure control with other treatments.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3735",
            "question": "How does lacosamide add\u2010on therapy compare with placebo for people with focal epilepsy?",
            "gold_answer": "Although lacosamide reduced seizure frequency for people with treatment\u2010resistant focal epilepsy compared with placebo, there was a concomitant increase in adverse events, particularly at higher doses, some ultimately leading to treatment withdrawal. For people with treatment\u2010resistant simple or complex focal seizures, with or without secondary generalized seizures, high\u2010certainty evidence shows that lacosamide (at 200, 400, or 600 mg daily) increases the number of people with at least 50% reduction in seizure frequency when compared with placebo (389 vs 216 per 1000 people had a 50% reduction; all results on average) but leads to increased treatment withdrawal at all doses (191 vs 122 per 1000 people; moderate\u2010certainty evidence). Ten adverse events seemed more commonly associated with lacosamide when the analysis included all doses (abnormal co\u2010ordination; ataxia; blurred vision; diplopia; dizziness; fatigue; nausea; somnolence; vertigo; vomiting). Abnormal vision showed higher rates with the highest dose (600 mg). Results for serious adverse events were imprecise. All five trials were sponsored by the manufacturers of lacosamide as part of the drug development program.",
            "gold_answer_terms": "PLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nSOMNOLENCE (somnolence): sleepiness",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3735",
            "llm_answer": "Lacosamide add-on therapy has been shown to be effective in reducing seizure frequency in people with focal epilepsy, compared to placebo. In a clinical trial published in the New England Journal of Medicine, lacosamide was added to the existing treatment regimen of patients with focal epilepsy who had not achieved seizure control with their current therapy. The study found that 40% of patients receiving lacosamide experienced a 50% or greater reduction in seizure frequency, compared to 23% of patients receiving placebo. Additionally, lacosamide was generally well-tolerated, with the most common adverse events being dizziness, headache, and nausea. However, it's important to note that lacosamide may not be effective for everyone with focal epilepsy, and its effectiveness can vary depending on the individual patient and the specific type of seizures they experience. It's important to consult with a healthcare professional to determine the best course of treatment for a specific patient.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How does lacosamide add\u2010on therapy compare with placebo for people with focal epilepsy?[/INST]",
            "topic1": [
                "child health",
                "neurology"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Antonio\u2010Santos, Aileen A."
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 138,
                            "score": 0.5,
                            "text": "Lacosamide add-on therapy has been shown to be effective in reducing seizure frequency in people with focal epilepsy, compared to placebo.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 139,
                            "end": 360,
                            "score": 0.5,
                            "text": "In a clinical trial published in the New England Journal of Medicine, lacosamide was added to the existing treatment regimen of patients with focal epilepsy who had not achieved seizure control with their current therapy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 361,
                            "end": 526,
                            "score": 0.5,
                            "text": "The study found that 40% of patients receiving lacosamide experienced a 50% or greater reduction in seizure frequency, compared to 23% of patients receiving placebo.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 527,
                            "end": 656,
                            "score": 0.5,
                            "text": "Additionally, lacosamide was generally well-tolerated, with the most common adverse events being dizziness, headache, and nausea.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 657,
                            "end": 877,
                            "score": 0.5,
                            "text": "However, it's important to note that lacosamide may not be effective for everyone with focal epilepsy, and its effectiveness can vary depending on the individual patient and the specific type of seizures they experience.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3735_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 878,
                            "end": 1000,
                            "score": 0.5,
                            "text": "It's important to consult with a healthcare professional to determine the best course of treatment for a specific patient.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3918",
            "question": "For adults with telangiectasias and reticular veins, how do sclerotherapy agents compare?",
            "gold_answer": "RCT evidence is insufficient to judge how sclerotherapy agents compare for adults with telangiectasias and reticular veins. When comparing polidocanol, sodium tetradecyl sulfate or hypertonic saline versus any other sclerosing agent for treatment of telangiectasias and reticular veins in adults, moderate\u2010certainty evidence shows that there is probably little to no difference among these agents in the resolution or improvement of telangiectasias. Compared with other sclerosing agents, pain was slightly lower with polidocanol (moderate\u2010certainty evidence) and much greater with hypertonic saline (moderate\u2010certainty evidence). More people experienced pain with sodium tetradecyl sulfate (on average, 387 vs 259 per 1000 people, although differences between groups did not reach statistical significance; moderate\u2010certainty evidence). With regard to adverse events, fewer people had necrosis with polidocanol; more people had hyperpigmentation, matting, bruising, allergy and/or necrosis with sodium tetradecyl sulfate and fewer people had hyperpigmentation with hypertonic saline. Recurrence and quality of life were not assessed in any comparison. Only a few underpowered studies compared chromated glycerin versus any other sclerosing agent, or polidocanol plus hypertonic glucose versus hypertonic glucose. No conclusions can be drawn from these comparisons.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nVEIN (vein): A blood vessel that takes blood towards the heart.\nNECROSIS (necrosis): death of tissue\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3918",
            "llm_answer": "Sclerotherapy agents used to treat telangiectasias and reticular veins include polidocanol, sodium tetradecyl sulfate, and hypertonic saline. Polidocanol is considered the most effective agent, with a higher success rate and longer-lasting results compared to sodium tetradecyl sulfate. Hypertonic saline is less effective but has fewer side effects. The choice of agent depends on the severity and location of the veins, as well as patient preferences and clinician experience.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For adults with telangiectasias and reticular veins, how do sclerotherapy agents compare?[/INST]",
            "topic1": [
                "heart circulation"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Tort, Sera; Vedamurthy, Deepak"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 141,
                            "score": 0.5,
                            "text": "Sclerotherapy agents used to treat telangiectasias and reticular veins include polidocanol, sodium tetradecyl sulfate, and hypertonic saline.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 142,
                            "end": 286,
                            "score": 0.5,
                            "text": "Polidocanol is considered the most effective agent, with a higher success rate and longer-lasting results compared to sodium tetradecyl sulfate.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 287,
                            "end": 350,
                            "score": 0.5,
                            "text": "Hypertonic saline is less effective but has fewer side effects.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 351,
                            "end": 478,
                            "score": 0.5,
                            "text": "The choice of agent depends on the severity and location of the veins, as well as patient preferences and clinician experience.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3918",
            "question": "For adults with telangiectasias and reticular veins, how do sclerotherapy agents compare?",
            "gold_answer": "RCT evidence is insufficient to judge how sclerotherapy agents compare for adults with telangiectasias and reticular veins. When comparing polidocanol, sodium tetradecyl sulfate or hypertonic saline versus any other sclerosing agent for treatment of telangiectasias and reticular veins in adults, moderate\u2010certainty evidence shows that there is probably little to no difference among these agents in the resolution or improvement of telangiectasias. Compared with other sclerosing agents, pain was slightly lower with polidocanol (moderate\u2010certainty evidence) and much greater with hypertonic saline (moderate\u2010certainty evidence). More people experienced pain with sodium tetradecyl sulfate (on average, 387 vs 259 per 1000 people, although differences between groups did not reach statistical significance; moderate\u2010certainty evidence). With regard to adverse events, fewer people had necrosis with polidocanol; more people had hyperpigmentation, matting, bruising, allergy and/or necrosis with sodium tetradecyl sulfate and fewer people had hyperpigmentation with hypertonic saline. Recurrence and quality of life were not assessed in any comparison. Only a few underpowered studies compared chromated glycerin versus any other sclerosing agent, or polidocanol plus hypertonic glucose versus hypertonic glucose. No conclusions can be drawn from these comparisons.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nVEIN (vein): A blood vessel that takes blood towards the heart.\nNECROSIS (necrosis): death of tissue\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3918",
            "llm_answer": "Sclerotherapy is a minimally invasive treatment for varicose veins, telangiectasias, and reticular veins. It involves injecting a solution into the affected vein, which causes the vein to collapse and eventually be absorbed by the body. There are several different sclerotherapy agents available, each with its own set of benefits and potential drawbacks.\nOne of the most commonly used sclerotherapy agents is sodium tetradecyl sulfate (STS). STS is a highly effective agent that has been used for decades to treat varicose veins and telangiectasias. It is a detergent-like solution that is injected into the vein, causing it to collapse and be absorbed by the body. STS is generally well-tolerated and has a good safety profile.\nAnother sclerotherapy agent is polidocanol. Polidocanol is a newer agent that has been shown to be as effective as STS in treating varicose veins and telangiectasias. It is also well-tolerated and has a good safety profile.\nA third sclerotherapy agent is asclera. Asclera is a newer agent that is specifically approved for the treatment of small varicose veins and telangiectasias. It is a foam solution that is injected into the vein, causing it to collapse and be absorbed by the body. Asclera has been shown to be effective and is generally well-tolerated.\nIt's important to note that the choice of sclerotherapy agent will depend on the specific needs of the patient and the severity of their condition. It's best to consult with a qualified healthcare professional to determine which agent is best for you.\nIn summary, STS, polidocanol, and asclera are all effective sclerotherapy agents for treating telangiectasias and reticular veins. It's important to consult with a qualified healthcare professional to determine which agent is best for your specific needs.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For adults with telangiectasias and reticular veins, how do sclerotherapy agents compare?[/INST]",
            "topic1": [
                "heart circulation"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Tort, Sera; Vedamurthy, Deepak"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 105,
                            "score": 0.5,
                            "text": "Sclerotherapy is a minimally invasive treatment for varicose veins, telangiectasias, and reticular veins.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 106,
                            "end": 236,
                            "score": 0.5,
                            "text": "It involves injecting a solution into the affected vein, which causes the vein to collapse and eventually be absorbed by the body.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 237,
                            "end": 355,
                            "score": 0.5,
                            "text": "There are several different sclerotherapy agents available, each with its own set of benefits and potential drawbacks.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 356,
                            "end": 442,
                            "score": 0.5,
                            "text": "One of the most commonly used sclerotherapy agents is sodium tetradecyl sulfate (STS).",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 443,
                            "end": 550,
                            "score": 0.5,
                            "text": "STS is a highly effective agent that has been used for decades to treat varicose veins and telangiectasias.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 551,
                            "end": 666,
                            "score": 0.5,
                            "text": "It is a detergent-like solution that is injected into the vein, causing it to collapse and be absorbed by the body.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 667,
                            "end": 729,
                            "score": 0.5,
                            "text": "STS is generally well-tolerated and has a good safety profile.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 730,
                            "end": 773,
                            "score": 0.5,
                            "text": "Another sclerotherapy agent is polidocanol.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 774,
                            "end": 896,
                            "score": 0.5,
                            "text": "Polidocanol is a newer agent that has been shown to be as effective as STS in treating varicose veins and telangiectasias.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 897,
                            "end": 953,
                            "score": 0.5,
                            "text": "It is also well-tolerated and has a good safety profile.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 954,
                            "end": 993,
                            "score": 0.5,
                            "text": "A third sclerotherapy agent is asclera.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 994,
                            "end": 1111,
                            "score": 0.5,
                            "text": "Asclera is a newer agent that is specifically approved for the treatment of small varicose veins and telangiectasias.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent12",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1112,
                            "end": 1217,
                            "score": 0.5,
                            "text": "It is a foam solution that is injected into the vein, causing it to collapse and be absorbed by the body.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent13",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1218,
                            "end": 1289,
                            "score": 0.5,
                            "text": "Asclera has been shown to be effective and is generally well-tolerated.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent14",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1290,
                            "end": 1437,
                            "score": 0.5,
                            "text": "It's important to note that the choice of sclerotherapy agent will depend on the specific needs of the patient and the severity of their condition.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent15",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1438,
                            "end": 1541,
                            "score": 0.5,
                            "text": "It's best to consult with a qualified healthcare professional to determine which agent is best for you.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent16",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1542,
                            "end": 1672,
                            "score": 0.5,
                            "text": "In summary, STS, polidocanol, and asclera are all effective sclerotherapy agents for treating telangiectasias and reticular veins.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3918_llama2_70b_chat_prompt1_answer_sent17",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1673,
                            "end": 1797,
                            "score": 0.5,
                            "text": "It's important to consult with a qualified healthcare professional to determine which agent is best for your specific needs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4048",
            "question": "How do antiepileptic drugs compare for people with generalized tonic\u2010clonic seizures?",
            "gold_answer": "Sodium valproate and lamotrigine seem to be superior to carbamazepine, phenobarbitone, and topiramate. They may be suitable for first\u2010line treatment for adults and children with idiopathic generalized tonic\u2010clonic seizures (GTCS) with or without other generalized seizure types. For people with idiopathic GTCS with or without other generalized seizure types, the following antiepileptic drugs were compared with each other in a network meta\u2010analysis: carbamazepine (CBZ), gabapentin (GBP), lacosamide (LCM), lamotrigine (LTG), levetiracetam (LEV), oxcarbazepine (OXC), phenobarbitone (PHB), phenytoin (PHT), topiramate (TPM), sodium valproate (VPS), and zonisamide (ZNS). The numbers of people withdrawing from treatment (primarily due to adverse events or lack of efficacy, or both) by the end of follow\u2010up were lower with VPS than with CBZ, PHB, LTG, TPM, and GBP, and lower with LTG than with CBZ, PHB, or TPM. Researchers did not report median times to treatment withdrawal. The certainty of evidence was moderate to high for comparisons with VPS. Regarding time to achieve 12 months' remission, there were little to no differences between groups for any comparison, either directly or in the network meta\u2010analysis (the certainty of the evidence was high for all drugs compared with VPS). People were more likely to remain seizure\u2010free during follow\u2010up with VPS than LTG. Researchers did not report adverse events separately for people with focal and idiopathic generalized tonic\u2010clonic seizures. Across 26 trials, the proportion of people experiencing an adverse event ranged from 76% with TPM to 43% with PHB; the proportion for LEV was unclear. The most commonly reported adverse events were drowsiness or fatigue (most common with CBZ, PHT, VPS, OXC, and GBP), headache or migraine (most common with LTG, LEV, ZNS, and LCM), dizziness or faintness (CBZ, PHT, and LEV), gastrointestinal disturbances (CBZ and PHT), and rash or skin disorders (CBZ and LTG).",
            "gold_answer_terms": "IDIOPATHIC (idiopathic): of unknown cause\nEFFICACY (efficacy): effectiveness\nREMISSION (remission): disappearance of evidence of cancer or other disease\nGASTROINTESTINAL (gastrointestinal): Relating to the stomach and intestine.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4048",
            "llm_answer": "Antiepileptic drugs (AEDs) can be effective in controlling generalized tonic-clonic seizures, but their efficacy can vary between individuals and drug classes. Some AEDs, such as valproate, levetiracetam, and lamotrigine, have been shown to be effective in reducing the frequency and severity of generalized tonic-clonic seizures. However, other AEDs, such as carbamazepine and phenytoin, may be less effective for this type of seizure. The choice of AED and its effectiveness will depend on individual patient factors, such as seizure frequency, severity, and EEG findings, as well as other health conditions and medication side effects. It is important to work closely with a healthcare provider to determine the most appropriate AED and dosage for each individual case.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How do antiepileptic drugs compare for people with generalized tonic\u2010clonic seizures?[/INST]",
            "topic1": [
                "child health",
                "neurology"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Tort, Sera; Ciapponi, Agust\u00edn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 159,
                            "score": 0.5,
                            "text": "Antiepileptic drugs (AEDs) can be effective in controlling generalized tonic-clonic seizures, but their efficacy can vary between individuals and drug classes.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 160,
                            "end": 330,
                            "score": 0.5,
                            "text": "Some AEDs, such as valproate, levetiracetam, and lamotrigine, have been shown to be effective in reducing the frequency and severity of generalized tonic-clonic seizures.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 331,
                            "end": 436,
                            "score": 0.5,
                            "text": "However, other AEDs, such as carbamazepine and phenytoin, may be less effective for this type of seizure.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 437,
                            "end": 638,
                            "score": 0.5,
                            "text": "The choice of AED and its effectiveness will depend on individual patient factors, such as seizure frequency, severity, and EEG findings, as well as other health conditions and medication side effects.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 639,
                            "end": 772,
                            "score": 0.5,
                            "text": "It is important to work closely with a healthcare provider to determine the most appropriate AED and dosage for each individual case.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.4048",
            "question": "How do antiepileptic drugs compare for people with generalized tonic\u2010clonic seizures?",
            "gold_answer": "Sodium valproate and lamotrigine seem to be superior to carbamazepine, phenobarbitone, and topiramate. They may be suitable for first\u2010line treatment for adults and children with idiopathic generalized tonic\u2010clonic seizures (GTCS) with or without other generalized seizure types. For people with idiopathic GTCS with or without other generalized seizure types, the following antiepileptic drugs were compared with each other in a network meta\u2010analysis: carbamazepine (CBZ), gabapentin (GBP), lacosamide (LCM), lamotrigine (LTG), levetiracetam (LEV), oxcarbazepine (OXC), phenobarbitone (PHB), phenytoin (PHT), topiramate (TPM), sodium valproate (VPS), and zonisamide (ZNS). The numbers of people withdrawing from treatment (primarily due to adverse events or lack of efficacy, or both) by the end of follow\u2010up were lower with VPS than with CBZ, PHB, LTG, TPM, and GBP, and lower with LTG than with CBZ, PHB, or TPM. Researchers did not report median times to treatment withdrawal. The certainty of evidence was moderate to high for comparisons with VPS. Regarding time to achieve 12 months' remission, there were little to no differences between groups for any comparison, either directly or in the network meta\u2010analysis (the certainty of the evidence was high for all drugs compared with VPS). People were more likely to remain seizure\u2010free during follow\u2010up with VPS than LTG. Researchers did not report adverse events separately for people with focal and idiopathic generalized tonic\u2010clonic seizures. Across 26 trials, the proportion of people experiencing an adverse event ranged from 76% with TPM to 43% with PHB; the proportion for LEV was unclear. The most commonly reported adverse events were drowsiness or fatigue (most common with CBZ, PHT, VPS, OXC, and GBP), headache or migraine (most common with LTG, LEV, ZNS, and LCM), dizziness or faintness (CBZ, PHT, and LEV), gastrointestinal disturbances (CBZ and PHT), and rash or skin disorders (CBZ and LTG).",
            "gold_answer_terms": "IDIOPATHIC (idiopathic): of unknown cause\nEFFICACY (efficacy): effectiveness\nREMISSION (remission): disappearance of evidence of cancer or other disease\nGASTROINTESTINAL (gastrointestinal): Relating to the stomach and intestine.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.4048",
            "llm_answer": "I am not a medical professional, but I can provide some general information about antiepileptic drugs (AEDs) and their effectiveness for people with generalized tonic-clonic seizures. It's important to note that the best treatment plan for an individual patient should be determined by a qualified healthcare professional, taking into account the patient's medical history, seizure type, and other factors.\nGeneralized tonic-clonic seizures, also known as grand mal seizures, are the most severe type of seizure and can be challenging to treat. AEDs are the primary treatment for epilepsy, and several AEDs have been shown to be effective in controlling generalized tonic-clonic seizures.\nSome AEDs that have been shown to be effective for generalized tonic-clonic seizures include:\n1. Levetiracetam (Keppra): This medication is commonly used as a first-line treatment for generalized epilepsy and has been shown to be effective in controlling generalized tonic-clonic seizures.\n2. Lamotrigine (Lamictal): This medication has been shown to be effective in controlling seizures in patients with generalized epilepsy, including generalized tonic-clonic seizures.\n3. Valproate (Depakote): This medication has been used for many years to treat various types of seizures, including generalized tonic-clonic seizures.\n4. Phenobarbital: This medication is an older AED that has been used for decades to treat all types of seizures, including generalized tonic-clonic seizures.\n5. Topiramate (Topamax): This medication has been shown to be effective in controlling seizures in patients with generalized epilepsy, including generalized tonic-clonic seizures.\nIt's important to note that each person's response to AEDs can vary, and it may take some trial and error to find the right medication and dosage that works best for an individual patient. Additionally, AEDs can have side effects, so it's important to work closely with a healthcare professional to monitor and manage any side effects.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How do antiepileptic drugs compare for people with generalized tonic\u2010clonic seizures?[/INST]",
            "topic1": [
                "child health",
                "neurology"
            ],
            "topic2": [],
            "year": 2022,
            "author": "Tort, Sera; Ciapponi, Agust\u00edn"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 183,
                            "score": 0.5,
                            "text": "I am not a medical professional, but I can provide some general information about antiepileptic drugs (AEDs) and their effectiveness for people with generalized tonic-clonic seizures.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 184,
                            "end": 406,
                            "score": 0.5,
                            "text": "It's important to note that the best treatment plan for an individual patient should be determined by a qualified healthcare professional, taking into account the patient's medical history, seizure type, and other factors.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 407,
                            "end": 544,
                            "score": 0.5,
                            "text": "Generalized tonic-clonic seizures, also known as grand mal seizures, are the most severe type of seizure and can be challenging to treat.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 545,
                            "end": 688,
                            "score": 0.5,
                            "text": "AEDs are the primary treatment for epilepsy, and several AEDs have been shown to be effective in controlling generalized tonic-clonic seizures.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 689,
                            "end": 782,
                            "score": 0.5,
                            "text": "Some AEDs that have been shown to be effective for generalized tonic-clonic seizures include:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 786,
                            "end": 978,
                            "score": 0.5,
                            "text": "Levetiracetam (Keppra): This medication is commonly used as a first-line treatment for generalized epilepsy and has been shown to be effective in controlling generalized tonic-clonic seizures.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 982,
                            "end": 1160,
                            "score": 0.5,
                            "text": "Lamotrigine (Lamictal): This medication has been shown to be effective in controlling seizures in patients with generalized epilepsy, including generalized tonic-clonic seizures.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1164,
                            "end": 1311,
                            "score": 0.5,
                            "text": "Valproate (Depakote): This medication has been used for many years to treat various types of seizures, including generalized tonic-clonic seizures.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1315,
                            "end": 1469,
                            "score": 0.5,
                            "text": "Phenobarbital: This medication is an older AED that has been used for decades to treat all types of seizures, including generalized tonic-clonic seizures.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1473,
                            "end": 1649,
                            "score": 0.5,
                            "text": "Topiramate (Topamax): This medication has been shown to be effective in controlling seizures in patients with generalized epilepsy, including generalized tonic-clonic seizures.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1650,
                            "end": 1838,
                            "score": 0.5,
                            "text": "It's important to note that each person's response to AEDs can vary, and it may take some trial and error to find the right medication and dosage that works best for an individual patient.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-4048_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1839,
                            "end": 1985,
                            "score": 0.5,
                            "text": "Additionally, AEDs can have side effects, so it's important to work closely with a healthcare professional to monitor and manage any side effects.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3762",
            "question": "How do high\u2010 and standard\u2010volume fortified enteral feeds compare for improving outcomes in preterm or low birthweight infants?",
            "gold_answer": "Moderate\u2010certainty evidence shows greater weight gain during hospital stay for infants who received high\u2010volume rather than standard\u2010volume feed (mean difference of around 2.58 g/kg/d). However, there were no clear differences between groups for all other major outcomes, including linear growth, head growth, proportion of infants with extrauterine growth restriction at discharge, incidence of necrotizing enterocolitis or feed interruption episodes, duration of hospital stay, or incidence of neurodevelopmental impairment at 12 months' corrected age, as supported by low\u2010 to very low\u2010certainty evidence or by a single RCT, indicating the presence of major uncertainties regarding study results. Rates of aspiration pneumonia or pneumonitis were not reported in any trial. Given that the included trials were conducted in the USA and in Australia, there may be a need to consider the applicability of findings in settings where neonatal care and monitoring capacities are different.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nASPIRATION (aspiration): fluid entering the lungs, such as after vomiting\nMONITOR (monitor): check on; keep track of; watch carefully",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3762",
            "llm_answer": "High-volume fortified enteral feeds have been shown to improve growth and neurodevelopmental outcomes in preterm or low birthweight infants compared to standard-volume fortified enteral feeds. High-volume feeds provide greater nutrient intake, which is important for catch-up growth and development in these high-risk infants. However, it's important to note that the optimal volume and composition of enteral feeds for preterm or low birthweight infants may vary depending on the individual infant's needs and clinical condition. Consultation with a healthcare professional is necessary to determine the most appropriate feeding regimen for each infant.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> How do high\u2010 and standard\u2010volume fortified enteral feeds compare for improving outcomes in preterm or low birthweight infants?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Lai, Nai Ming"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 192,
                            "score": 0.5,
                            "text": "High-volume fortified enteral feeds have been shown to improve growth and neurodevelopmental outcomes in preterm or low birthweight infants compared to standard-volume fortified enteral feeds.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 193,
                            "end": 326,
                            "score": 0.5,
                            "text": "High-volume feeds provide greater nutrient intake, which is important for catch-up growth and development in these high-risk infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 327,
                            "end": 530,
                            "score": 0.5,
                            "text": "However, it's important to note that the optimal volume and composition of enteral feeds for preterm or low birthweight infants may vary depending on the individual infant's needs and clinical condition.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 531,
                            "end": 654,
                            "score": 0.5,
                            "text": "Consultation with a healthcare professional is necessary to determine the most appropriate feeding regimen for each infant.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3762",
            "question": "How do high\u2010 and standard\u2010volume fortified enteral feeds compare for improving outcomes in preterm or low birthweight infants?",
            "gold_answer": "Moderate\u2010certainty evidence shows greater weight gain during hospital stay for infants who received high\u2010volume rather than standard\u2010volume feed (mean difference of around 2.58 g/kg/d). However, there were no clear differences between groups for all other major outcomes, including linear growth, head growth, proportion of infants with extrauterine growth restriction at discharge, incidence of necrotizing enterocolitis or feed interruption episodes, duration of hospital stay, or incidence of neurodevelopmental impairment at 12 months' corrected age, as supported by low\u2010 to very low\u2010certainty evidence or by a single RCT, indicating the presence of major uncertainties regarding study results. Rates of aspiration pneumonia or pneumonitis were not reported in any trial. Given that the included trials were conducted in the USA and in Australia, there may be a need to consider the applicability of findings in settings where neonatal care and monitoring capacities are different.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nASPIRATION (aspiration): fluid entering the lungs, such as after vomiting\nMONITOR (monitor): check on; keep track of; watch carefully",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3762",
            "llm_answer": "High-volume fortified enteral feeds and standard-volume fortified enteral feeds are both used to support the growth and development of preterm or low birthweight infants. However, they differ in their nutrient content and caloric density.\nHigh-volume fortified enteral feeds are designed to provide higher amounts of nutrients, such as protein, minerals, and vitamins, compared to standard-volume fortified enteral feeds. These feeds are typically used for infants who require a higher caloric intake to support their growth and development, such as those who are born extremely preterm or have a low birthweight.\nOn the other hand, standard-volume fortified enteral feeds are designed to provide a standard amount of nutrients and calories that are appropriate for most preterm or low birthweight infants.\nThere is evidence to suggest that high-volume fortified enteral feeds may improve outcomes in preterm or low birthweight infants, such as increased weight gain and improved growth rates, compared to standard-volume fortified enteral feeds. However, it's important to note that the optimal nutrient and caloric content for enteral feeds can vary depending on the individual infant's needs and medical condition.\nIt's important to consult with a healthcare professional to determine the appropriate type and volume of enteral feed for a preterm or low birthweight infant, as they can assess the infant's individual needs and adjust the feeding regimen accordingly. Additionally, it's important to ensure that the enteral feed is administered safely and in a way that minimizes the risk of complications, such as aspiration or feeding intolerance.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> How do high\u2010 and standard\u2010volume fortified enteral feeds compare for improving outcomes in preterm or low birthweight infants?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Lai, Nai Ming"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 170,
                            "score": 0.5,
                            "text": "High-volume fortified enteral feeds and standard-volume fortified enteral feeds are both used to support the growth and development of preterm or low birthweight infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 171,
                            "end": 238,
                            "score": 0.5,
                            "text": "However, they differ in their nutrient content and caloric density.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 239,
                            "end": 421,
                            "score": 0.5,
                            "text": "High-volume fortified enteral feeds are designed to provide higher amounts of nutrients, such as protein, minerals, and vitamins, compared to standard-volume fortified enteral feeds.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 422,
                            "end": 613,
                            "score": 0.5,
                            "text": "These feeds are typically used for infants who require a higher caloric intake to support their growth and development, such as those who are born extremely preterm or have a low birthweight.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 614,
                            "end": 806,
                            "score": 0.5,
                            "text": "On the other hand, standard-volume fortified enteral feeds are designed to provide a standard amount of nutrients and calories that are appropriate for most preterm or low birthweight infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 807,
                            "end": 1046,
                            "score": 0.5,
                            "text": "There is evidence to suggest that high-volume fortified enteral feeds may improve outcomes in preterm or low birthweight infants, such as increased weight gain and improved growth rates, compared to standard-volume fortified enteral feeds.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1047,
                            "end": 1217,
                            "score": 0.5,
                            "text": "However, it's important to note that the optimal nutrient and caloric content for enteral feeds can vary depending on the individual infant's needs and medical condition.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1218,
                            "end": 1469,
                            "score": 0.5,
                            "text": "It's important to consult with a healthcare professional to determine the appropriate type and volume of enteral feed for a preterm or low birthweight infant, as they can assess the infant's individual needs and adjust the feeding regimen accordingly.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3762_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1470,
                            "end": 1651,
                            "score": 0.5,
                            "text": "Additionally, it's important to ensure that the enteral feed is administered safely and in a way that minimizes the risk of complications, such as aspiration or feeding intolerance.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3298",
            "question": "For people with cystic fibrosis, how do biotechnology\u2010derived and porcine pancreatic enzyme replacement therapy (PERT) compare?",
            "gold_answer": "Reviewers identified one RCT including 128 participants with cystic fibrosis (specific mutations not reported; mean age 22 years) comparing biotechnology\u2010derived non\u2010porcine PERT (liprotamase) with porcine PERT (pancrelipase). This RCT was designed as a non\u2010inferiority trial; trialists chose a non\u2010inferiority margin of \u201015% (maximum reduction in efficacy of 15%) to classify liprotamase as non\u2010inferior to pancrelipase. This low\u2010certainty evidence suggests that by seven weeks, the coefficient of fat absorption (CFA) was unchanged with pancrelipase (approx. 89.5%; all results on average) but was reduced with liprotamase (from 88.7% to 76.5%). Although the average reduction with liprotamase of 11% was within the non\u2010inferiority margin, the lower confidence interval was 16%, exceeding the 15% non\u2010inferiority margin; therefore, based on this small trial, liprotamase could not be confirmed as non\u2010inferior to pancrelipase. Evidence for other reported efficacy outcomes suggests little to no difference between groups (change in weight and height) and no benefit of pancrelipase (abdominal pain), or the result was imprecise (pulmonary exacerbation). This RCT reported similar rates of adverse events in the two groups (63% vs 60%). Given available evidence, no firm conclusions can be drawn as to the relative efficacy and safety of biotechnology\u2010derived and porcine PERT.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nEFFICACY (efficacy): effectiveness\nABDOMINAL (abdominal): Of the abdomen.\nPULMONARY (pulmonary): pertaining to the lungs",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3298",
            "llm_answer": "Biotechnology-derived and porcine pancreatic enzyme replacement therapy (PERT) are both effective treatments for pancreatic insufficiency in people with cystic fibrosis. However, biotechnology-derived enzymes have several advantages over porcine PERT, including:\n1. Improved efficacy: Biotechnology-derived enzymes have been shown to be more effective in improving nutritional status and reducing symptoms compared to porcine PERT.\n2. Reduced risk of infection: Biotechnology-derived enzymes are less likely to transmit infectious agents, such as porcine endogenous retroviruses (PERVs), which have been identified in porcine PERT.\n3. Better tolerability: Biotechnology-derived enzymes have been associated with fewer side effects and better tolerability compared to porcine PERT.\n4. More convenient administration: Biotechnology-derived enzymes can be administered in a variety of formulations, including capsules, tablets, and powders, which may be more convenient for patients than the liquid formulation of porcine PERT.\nOverall, biotechnology-derived enzymes are considered a safer and more effective treatment option for pancreatic insufficiency in people with cystic fibrosis compared to porcine PERT.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> For people with cystic fibrosis, how do biotechnology\u2010derived and porcine pancreatic enzyme replacement therapy (PERT) compare?[/INST]",
            "topic1": [
                "child health",
                "gastroenterology hepatology"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Mulhem, Elie"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 169,
                            "score": 0.5,
                            "text": "Biotechnology-derived and porcine pancreatic enzyme replacement therapy (PERT) are both effective treatments for pancreatic insufficiency in people with cystic fibrosis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 170,
                            "end": 262,
                            "score": 0.5,
                            "text": "However, biotechnology-derived enzymes have several advantages over porcine PERT, including:",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 266,
                            "end": 431,
                            "score": 0.5,
                            "text": "Improved efficacy: Biotechnology-derived enzymes have been shown to be more effective in improving nutritional status and reducing symptoms compared to porcine PERT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 435,
                            "end": 631,
                            "score": 0.5,
                            "text": "Reduced risk of infection: Biotechnology-derived enzymes are less likely to transmit infectious agents, such as porcine endogenous retroviruses (PERVs), which have been identified in porcine PERT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 635,
                            "end": 780,
                            "score": 0.5,
                            "text": "Better tolerability: Biotechnology-derived enzymes have been associated with fewer side effects and better tolerability compared to porcine PERT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt0_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 784,
                            "end": 1024,
                            "score": 0.5,
                            "text": "More convenient administration: Biotechnology-derived enzymes can be administered in a variety of formulations, including capsules, tablets, and powders, which may be more convenient for patients than the liquid formulation of porcine PERT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt0_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1025,
                            "end": 1208,
                            "score": 0.5,
                            "text": "Overall, biotechnology-derived enzymes are considered a safer and more effective treatment option for pancreatic insufficiency in people with cystic fibrosis compared to porcine PERT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.3298",
            "question": "For people with cystic fibrosis, how do biotechnology\u2010derived and porcine pancreatic enzyme replacement therapy (PERT) compare?",
            "gold_answer": "Reviewers identified one RCT including 128 participants with cystic fibrosis (specific mutations not reported; mean age 22 years) comparing biotechnology\u2010derived non\u2010porcine PERT (liprotamase) with porcine PERT (pancrelipase). This RCT was designed as a non\u2010inferiority trial; trialists chose a non\u2010inferiority margin of \u201015% (maximum reduction in efficacy of 15%) to classify liprotamase as non\u2010inferior to pancrelipase. This low\u2010certainty evidence suggests that by seven weeks, the coefficient of fat absorption (CFA) was unchanged with pancrelipase (approx. 89.5%; all results on average) but was reduced with liprotamase (from 88.7% to 76.5%). Although the average reduction with liprotamase of 11% was within the non\u2010inferiority margin, the lower confidence interval was 16%, exceeding the 15% non\u2010inferiority margin; therefore, based on this small trial, liprotamase could not be confirmed as non\u2010inferior to pancrelipase. Evidence for other reported efficacy outcomes suggests little to no difference between groups (change in weight and height) and no benefit of pancrelipase (abdominal pain), or the result was imprecise (pulmonary exacerbation). This RCT reported similar rates of adverse events in the two groups (63% vs 60%). Given available evidence, no firm conclusions can be drawn as to the relative efficacy and safety of biotechnology\u2010derived and porcine PERT.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nEFFICACY (efficacy): effectiveness\nABDOMINAL (abdominal): Of the abdomen.\nPULMONARY (pulmonary): pertaining to the lungs",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.3298",
            "llm_answer": "Biotechnology-derived and porcine pancreatic enzyme replacement therapy (PERT) are both used to treat digestive problems associated with cystic fibrosis, a genetic disorder that affects the respiratory, digestive, and reproductive systems.\nBiotechnology-derived PERT, also known as synthetic PERT, uses genetically engineered bacteria to produce pancreatic enzymes that are identical to those produced by the human pancreas. These enzymes are then purified and formulated into capsules or tablets that can be taken with meals to help break down food and absorb nutrients.\nPorcine PERT, on the other hand, uses pancreatic enzymes derived from pigs. These enzymes are extracted from the pancreas of pigs and then purified and formulated into capsules or tablets.\nBoth biotechnology-derived and porcine PERT have been shown to be effective in improving nutritional status and reducing symptoms such as abdominal pain, diarrhea, and fatty stools in people with cystic fibrosis. However, biotechnology-derived PERT has several advantages over porcine PERT.\nFirstly, biotechnology-derived PERT is less likely to cause an allergic reaction, as it does not contain any animal products. This is important because people with cystic fibrosis are at a higher risk of developing allergies.\nSecondly, biotechnology-derived PERT has a more consistent and predictable composition, as the enzymes are produced through a controlled fermentation process. This means that the amount and type of enzymes in each dose can be more accurately controlled, which can help to optimize the effectiveness of the treatment.\nLastly, biotechnology-derived PERT is generally better tolerated and has fewer side effects than porcine PERT. Some people may experience gastrointestinal symptoms such as nausea, vomiting, and abdominal pain when taking porcine PERT, possibly due to the animal origin of the enzymes.\nIn summary, while both",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> For people with cystic fibrosis, how do biotechnology\u2010derived and porcine pancreatic enzyme replacement therapy (PERT) compare?[/INST]",
            "topic1": [
                "child health",
                "gastroenterology hepatology"
            ],
            "topic2": [],
            "year": 2021,
            "author": "Burch, Jane; Mulhem, Elie"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 239,
                            "score": 0.5,
                            "text": "Biotechnology-derived and porcine pancreatic enzyme replacement therapy (PERT) are both used to treat digestive problems associated with cystic fibrosis, a genetic disorder that affects the respiratory, digestive, and reproductive systems.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 240,
                            "end": 424,
                            "score": 0.5,
                            "text": "Biotechnology-derived PERT, also known as synthetic PERT, uses genetically engineered bacteria to produce pancreatic enzymes that are identical to those produced by the human pancreas.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 425,
                            "end": 571,
                            "score": 0.5,
                            "text": "These enzymes are then purified and formulated into capsules or tablets that can be taken with meals to help break down food and absorb nutrients.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 572,
                            "end": 647,
                            "score": 0.5,
                            "text": "Porcine PERT, on the other hand, uses pancreatic enzymes derived from pigs.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 648,
                            "end": 760,
                            "score": 0.5,
                            "text": "These enzymes are extracted from the pancreas of pigs and then purified and formulated into capsules or tablets.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 761,
                            "end": 973,
                            "score": 0.5,
                            "text": "Both biotechnology-derived and porcine PERT have been shown to be effective in improving nutritional status and reducing symptoms such as abdominal pain, diarrhea, and fatty stools in people with cystic fibrosis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 974,
                            "end": 1051,
                            "score": 0.5,
                            "text": "However, biotechnology-derived PERT has several advantages over porcine PERT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1052,
                            "end": 1177,
                            "score": 0.5,
                            "text": "Firstly, biotechnology-derived PERT is less likely to cause an allergic reaction, as it does not contain any animal products.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent8",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1178,
                            "end": 1277,
                            "score": 0.5,
                            "text": "This is important because people with cystic fibrosis are at a higher risk of developing allergies.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent9",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1278,
                            "end": 1436,
                            "score": 0.5,
                            "text": "Secondly, biotechnology-derived PERT has a more consistent and predictable composition, as the enzymes are produced through a controlled fermentation process.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent10",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1437,
                            "end": 1594,
                            "score": 0.5,
                            "text": "This means that the amount and type of enzymes in each dose can be more accurately controlled, which can help to optimize the effectiveness of the treatment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent11",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1595,
                            "end": 1705,
                            "score": 0.5,
                            "text": "Lastly, biotechnology-derived PERT is generally better tolerated and has fewer side effects than porcine PERT.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent12",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1706,
                            "end": 1879,
                            "score": 0.5,
                            "text": "Some people may experience gastrointestinal symptoms such as nausea, vomiting, and abdominal pain when taking porcine PERT, possibly due to the animal origin of the enzymes.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-3298_llama2_70b_chat_prompt1_answer_sent13",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1880,
                            "end": 1902,
                            "score": 0.5,
                            "text": "In summary, while both",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.1303",
            "question": "What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?",
            "gold_answer": "High\u2010quality evidence shows that children and adults with a clinical diagnosis of tuberculosis (TB) meningitis receiving an anti\u2010TB regimen are less likely to die within 24 months when an adjunctive corticosteroid is administered (312 versus 413 per 1000 people died with an adjunctive corticosteroid compared with no corticosteroid, respectively). Moderate\u2010quality evidence showed that this benefit was not sustained in the longer\u2010term (5 years). Low\u2010quality evidence suggests there was no benefit of an adjunctive corticosteroid in terms of reducing rates of disabling neurological deficit, ether within 24 months or at 5 years. There was no apparent impact of adjunctive corticosteroids on the incidences of hepatitis, hyperglycemia/glycosuria, gastrointestinal bleeding, or invasive bacterial infection but event rates were very low meaning conclusions cannot be drawn.",
            "gold_answer_terms": "CLINICAL (clinical): pertaining to medical care\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.\nMENINGITIS (meningitis): Inflammation in the brain caused by a virus or bacteria.\nREGIMEN (regimen): pattern of giving treatment\nCORTICOSTEROIDS (corticosteroids): A group of hormones which may be used to suppress the body\u2019s immune response or to reduce inflammation. Also used during pregnancy in women who are thought may have their baby prematurely. They reduce the chance of the baby having problems from being born prematurely. See also steroids.\nTERM (term): Between 37 and 42 weeks of pregnancy.\nNEUROLOGICAL (neurological): pertaining to the nervous system\nGASTROINTESTINAL (gastrointestinal): Relating to the stomach and intestine.\nINVASIVE (invasive): A medical procedure when a cut is made to the body or an instrument is inserted.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.1303",
            "llm_answer": "Adjunctive corticosteroids have been shown to improve mortality and disability outcomes in people with tuberculous meningitis. Studies have consistently demonstrated that corticosteroids reduce the risk of death and disability in patients with tuberculous meningitis, particularly in those with severe disease. The use of corticosteroids has been associated with a significant reduction in mortality rates, from approximately 30-40% in untreated patients to around 10-20% in patients receiving corticosteroids. Additionally, corticosteroids have been shown to reduce the risk of long-term disability, such as hearing loss and cognitive impairment. However, the optimal dosage and duration of corticosteroid therapy for tuberculous meningitis are still uncertain and require further research.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?[/INST]",
            "topic1": [
                "child health",
                "infectious disease",
                "lungs airways"
            ],
            "topic2": [
                "respiratory infections"
            ],
            "year": 2016,
            "author": "Burch, Jane; Eisenhut, Michael"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 126,
                            "score": 0.5,
                            "text": "Adjunctive corticosteroids have been shown to improve mortality and disability outcomes in people with tuberculous meningitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 127,
                            "end": 310,
                            "score": 0.5,
                            "text": "Studies have consistently demonstrated that corticosteroids reduce the risk of death and disability in patients with tuberculous meningitis, particularly in those with severe disease.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 311,
                            "end": 510,
                            "score": 0.5,
                            "text": "The use of corticosteroids has been associated with a significant reduction in mortality rates, from approximately 30-40% in untreated patients to around 10-20% in patients receiving corticosteroids.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 511,
                            "end": 647,
                            "score": 0.5,
                            "text": "Additionally, corticosteroids have been shown to reduce the risk of long-term disability, such as hearing loss and cognitive impairment.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt0_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 648,
                            "end": 791,
                            "score": 0.5,
                            "text": "However, the optimal dosage and duration of corticosteroid therapy for tuberculous meningitis are still uncertain and require further research.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.1303",
            "question": "What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?",
            "gold_answer": "High\u2010quality evidence shows that children and adults with a clinical diagnosis of tuberculosis (TB) meningitis receiving an anti\u2010TB regimen are less likely to die within 24 months when an adjunctive corticosteroid is administered (312 versus 413 per 1000 people died with an adjunctive corticosteroid compared with no corticosteroid, respectively). Moderate\u2010quality evidence showed that this benefit was not sustained in the longer\u2010term (5 years). Low\u2010quality evidence suggests there was no benefit of an adjunctive corticosteroid in terms of reducing rates of disabling neurological deficit, ether within 24 months or at 5 years. There was no apparent impact of adjunctive corticosteroids on the incidences of hepatitis, hyperglycemia/glycosuria, gastrointestinal bleeding, or invasive bacterial infection but event rates were very low meaning conclusions cannot be drawn.",
            "gold_answer_terms": "CLINICAL (clinical): pertaining to medical care\nDIAGNOSIS (diagnosis): The way a medical professional recognises a condition or disease.\nMENINGITIS (meningitis): Inflammation in the brain caused by a virus or bacteria.\nREGIMEN (regimen): pattern of giving treatment\nCORTICOSTEROIDS (corticosteroids): A group of hormones which may be used to suppress the body\u2019s immune response or to reduce inflammation. Also used during pregnancy in women who are thought may have their baby prematurely. They reduce the chance of the baby having problems from being born prematurely. See also steroids.\nTERM (term): Between 37 and 42 weeks of pregnancy.\nNEUROLOGICAL (neurological): pertaining to the nervous system\nGASTROINTESTINAL (gastrointestinal): Relating to the stomach and intestine.\nINVASIVE (invasive): A medical procedure when a cut is made to the body or an instrument is inserted.",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.1303",
            "llm_answer": "Adjunctive corticosteroids have been found to improve mortality and disability outcomes in people with tuberculous meningitis. According to a systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews, corticosteroids reduced the risk of death and disability in patients with tuberculous meningitis by 27% and 23%, respectively, compared to those who did not receive corticosteroids. However, the review also noted that the quality of the evidence was generally low and that further research is needed to confirm these findings. It's important to note that corticosteroids should only be used under the guidance of a healthcare professional and in conjunction with appropriate antituberculous therapy.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> What effect do adjunctive corticosteroids have on mortality and disability in people with tuberculous meningitis?[/INST]",
            "topic1": [
                "child health",
                "infectious disease",
                "lungs airways"
            ],
            "topic2": [
                "respiratory infections"
            ],
            "year": 2016,
            "author": "Burch, Jane; Eisenhut, Michael"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 126,
                            "score": 0.5,
                            "text": "Adjunctive corticosteroids have been found to improve mortality and disability outcomes in people with tuberculous meningitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 127,
                            "end": 417,
                            "score": 0.5,
                            "text": "According to a systematic review and meta-analysis published in the Cochrane Database of Systematic Reviews, corticosteroids reduced the risk of death and disability in patients with tuberculous meningitis by 27% and 23%, respectively, compared to those who did not receive corticosteroids.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 418,
                            "end": 562,
                            "score": 0.5,
                            "text": "However, the review also noted that the quality of the evidence was generally low and that further research is needed to confirm these findings.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-1303_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 563,
                            "end": 735,
                            "score": 0.5,
                            "text": "It's important to note that corticosteroids should only be used under the guidance of a healthcare professional and in conjunction with appropriate antituberculous therapy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.2493",
            "question": "Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?",
            "gold_answer": "Reviewers found no conclusive RCT evidence suggesting that administration of probiotics to pregnant women was superior or inferior to placebo in reducing morbidity or mortality in preterm infants. Low\u2010certainty evidence suggests that in pregnant women who received probiotics, the risk of preterm birth (< 37 weeks) and miscarriage/stillbirth was no more or less likely compared with those who did not receive probiotics. Only one RCT (159 infants) reported no incidences of early neonatal sepsis (\u2264 3 days) in either trial arm. For most outcomes, event rates were very low or there were no events in both arms. There is a lack of data on neonatal short\u2010term (early or late sepsis, necrotizing enterocolitis, neonatal death, hospital stay) and long\u2010term (major neurodevelopmental disability) potential benefits or harms following probiotic administration. None of the trials included women with a previous history of preterm birth, multiple pregnancy, or uterine anomaly. Reviewers did not assess serious adverse maternal or neonatal adverse events following use of probiotics.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nMORBIDITY (morbidity): undesired result or complication\nMORTALITY (mortality): death\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nSEPSIS (sepsis): The immune system's overreaction to an infection or injury which can lead to tissue damage, organ failure, and death.\nPOTENTIAL (potential): possible\nPOTENTIATE (potentiate): increase or multiply the effect of a drug or toxin (poison) by giving another drug or toxin at the same time (sometimes an unintentional result)\nPOTENTIATOR (potentiator): an agent that helps another agent work better\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.2493",
            "llm_answer": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants. Studies have found that probiotics can help reduce the risk of preterm birth, necrotizing enterocolitis, and other complications in preterm infants. However, it's important to note that the efficacy of probiotics may vary depending on the specific strain and dosage used, and more research is needed to fully understand their benefits and potential risks. It's recommended to consult with a healthcare provider before taking probiotics during pregnancy.",
            "llm_model_name": "llama2_70b_chat_prompt0_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> Provide a concise answer for the following question. <</SYS>> Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2019,
            "author": "Kamath, Mohan S"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 122,
                            "score": 0.5,
                            "text": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 123,
                            "end": 271,
                            "score": 0.5,
                            "text": "Studies have found that probiotics can help reduce the risk of preterm birth, necrotizing enterocolitis, and other complications in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 272,
                            "end": 478,
                            "score": 0.5,
                            "text": "However, it's important to note that the efficacy of probiotics may vary depending on the specific strain and dosage used, and more research is needed to fully understand their benefits and potential risks.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt0_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 479,
                            "end": 576,
                            "score": 0.5,
                            "text": "It's recommended to consult with a healthcare provider before taking probiotics during pregnancy.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    },
    {
        "data": {
            "doi": "10.1002/cca.2493",
            "question": "Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?",
            "gold_answer": "Reviewers found no conclusive RCT evidence suggesting that administration of probiotics to pregnant women was superior or inferior to placebo in reducing morbidity or mortality in preterm infants. Low\u2010certainty evidence suggests that in pregnant women who received probiotics, the risk of preterm birth (< 37 weeks) and miscarriage/stillbirth was no more or less likely compared with those who did not receive probiotics. Only one RCT (159 infants) reported no incidences of early neonatal sepsis (\u2264 3 days) in either trial arm. For most outcomes, event rates were very low or there were no events in both arms. There is a lack of data on neonatal short\u2010term (early or late sepsis, necrotizing enterocolitis, neonatal death, hospital stay) and long\u2010term (major neurodevelopmental disability) potential benefits or harms following probiotic administration. None of the trials included women with a previous history of preterm birth, multiple pregnancy, or uterine anomaly. Reviewers did not assess serious adverse maternal or neonatal adverse events following use of probiotics.",
            "gold_answer_terms": "RCT (rct): A study which tests the effectiveness and safety of treatments or procedures as fairly and objectively as possible. By randomly assigning patients to different treatments for the same problem, the results can be assessed equally with the aim of discovering the best possible procedure for the condition.\nPLACEBO (placebo): an inactive substance; a pill/liquid that contains no medicine\nMORBIDITY (morbidity): undesired result or complication\nMORTALITY (mortality): death\nRISK (risk): The chance that an activity or hazard will give rise to harm. Risk is generally given in terms of numerical odds (1 in 10) or percentages (10%).\nSEPSIS (sepsis): The immune system's overreaction to an infection or injury which can lead to tissue damage, organ failure, and death.\nPOTENTIAL (potential): possible\nPOTENTIATE (potentiate): increase or multiply the effect of a drug or toxin (poison) by giving another drug or toxin at the same time (sometimes an unintentional result)\nPOTENTIATOR (potentiator): an agent that helps another agent work better\nASSESS (assess): to learn about, measure, evaluate, look at",
            "url": "https://www.cochranelibrary.com/cca/doi/10.1002/cca.2493",
            "llm_answer": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants. Probiotics are beneficial bacteria that can help maintain a healthy gut microbiome, which is important for the development and function of various bodily systems, including the immune system.\nStudies have found that probiotics can help reduce the risk of preterm birth, which is a leading cause of neonatal morbidity and mortality. Probiotics have also been shown to reduce the risk of other complications in preterm infants, such as necrotizing enterocolitis, a serious condition that can cause damage to the intestines.\nIt's important to note that not all probiotics are the same, and some strains have been found to be more effective than others in preventing morbidity and mortality in preterm infants. For example, the probiotic strain Lactobacillus rhamnosus GG has been shown to be effective in reducing the risk of necrotizing enterocolitis.\nIt's important to consult with a healthcare provider before taking any supplements during pregnancy, including probiotics, to ensure safety and effectiveness. Additionally, it's important to note that while probiotics can help reduce the risk of complications, they are not a guarantee against them, and other factors such as proper prenatal care, a healthy diet, and a safe delivery are also important for a healthy pregnancy and baby.",
            "llm_model_name": "llama2_70b_chat_prompt1_answer",
            "llm_model_prompt": "<s>[INST] <<SYS>> You are a helpful, respectful and honest assistant. Provide a concise answer for the following question. Always answer as helpfully as possible, while being safe.  Your answers should not include any harmful, unethical, racist, sexist, toxic, dangerous, or illegal content. Please ensure that your responses are socially unbiased and positive in nature. If a question does not make any sense, or is not factually coherent, explain why instead of answering something not correct. If you don't know the answer to a question, please don't share false information. <</SYS>> Can probiotics administered to pregnant women help prevent morbidity and mortality in preterm infants?[/INST]",
            "topic1": [
                "child health"
            ],
            "topic2": [],
            "year": 2019,
            "author": "Kamath, Mohan S"
        },
        "predictions": [
            {
                "model_version": "0.1",
                "score": 0.5,
                "result": [
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer",
                        "from_name": "llm_answer_label_1",
                        "to_name": "llm_answer_eval_1",
                        "type": "choices",
                        "value": {
                            "choices": [
                                "Valid"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent0",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 0,
                            "end": 122,
                            "score": 0.5,
                            "text": "Yes, probiotics administered to pregnant women have been shown to help prevent morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent1",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 123,
                            "end": 314,
                            "score": 0.5,
                            "text": "Probiotics are beneficial bacteria that can help maintain a healthy gut microbiome, which is important for the development and function of various bodily systems, including the immune system.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent2",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 315,
                            "end": 454,
                            "score": 0.5,
                            "text": "Studies have found that probiotics can help reduce the risk of preterm birth, which is a leading cause of neonatal morbidity and mortality.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent3",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 455,
                            "end": 644,
                            "score": 0.5,
                            "text": "Probiotics have also been shown to reduce the risk of other complications in preterm infants, such as necrotizing enterocolitis, a serious condition that can cause damage to the intestines.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent4",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 645,
                            "end": 829,
                            "score": 0.5,
                            "text": "It's important to note that not all probiotics are the same, and some strains have been found to be more effective than others in preventing morbidity and mortality in preterm infants.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent5",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 830,
                            "end": 972,
                            "score": 0.5,
                            "text": "For example, the probiotic strain Lactobacillus rhamnosus GG has been shown to be effective in reducing the risk of necrotizing enterocolitis.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent6",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 973,
                            "end": 1131,
                            "score": 0.5,
                            "text": "It's important to consult with a healthcare provider before taking any supplements during pregnancy, including probiotics, to ensure safety and effectiveness.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    },
                    {
                        "id": "10-1002_cca-2493_llama2_70b_chat_prompt1_answer_sent7",
                        "from_name": "llm_answer_fine_grain_label",
                        "to_name": "llm_answer_eval_2",
                        "type": "labels",
                        "value": {
                            "start": 1132,
                            "end": 1409,
                            "score": 0.5,
                            "text": "Additionally, it's important to note that while probiotics can help reduce the risk of complications, they are not a guarantee against them, and other factors such as proper prenatal care, a healthy diet, and a safe delivery are also important for a healthy pregnancy and baby.",
                            "labels": [
                                "Cannot assess"
                            ]
                        }
                    }
                ]
            }
        ]
    }
]